UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549


FORM 10-Q


FORM 10-Q

 

(Mark one)

☒         QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended March 31, 20222023

 

or

 

☐         TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from                         to                         .

 

Commission File Number: 000-24248

Commission File Number: 000-24248


logo.jpg

img01.jpg

 

GENASYS INC.

(Exact name of registrant as specified in its charter)


(Exact name of registrant as specified in its charter)

Delaware

87-0361799

(State or other jurisdiction of

incorporation or organization)

(I.R.S. Employer

Identification Number)

  

16262 West Bernardo Drive, San Diego,

California

92127

(Address of principal executive offices)

(Zip Code)

 

(858) 676-1112

(RegistrantsRegistrant’s telephone number, including area code)


 

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which securities are registered

Common stock, $0.00001 par value per share

GNSS

NASDAQ Capital Market

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.       Yes  ☒     YesNo ☐  No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).      Yes ☒     YesNo ☐  No


 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer”, “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer

Accelerated filer

    

Non-accelerated filer

Smaller reporting company

    

Emerging growth company

  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.    ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).      Yes ☐      YesNo  ☒    No

 

The number of shares of Common Stock, $0.00001 par value, outstanding on May 5, 20223, 2023 was 36,578,085.36,984,295.



 

 

 

PART I. FINANCIAL INFORMATION

 

Item1.Financial Statements

Item 1.

Financial Statements

Genasys Inc.

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except par value and share amounts)

 

 

March 31,

     

March 31,

    
 

2022

 

September 30,

  

2023

 

September 30,

 
 

(Unaudited)

  

2021

  

(Unaudited)

  

2022

 

ASSETS

  

Current assets:

  

Cash and cash equivalents

 $8,977  $13,167  $6,371  $12,736 

Short-term marketable securities

 5,204  5,686  5,552  6,397 

Restricted cash

 267  279  739  100 

Accounts receivable, net

 5,550  7,682 

Accounts receivable, net of allowance for doubtful accounts of $181

 3,623  6,744 

Inventories, net

 9,642  6,416  9,387  6,008 

Prepaid expenses and other

  1,479   2,255   1,613   3,577 

Total current assets

 31,119  35,485  27,285  35,562 
  

Long-term marketable securities

 2,264  1,875  601  781 

Long-term restricted cash

 1,096  1,082  96  823 

Deferred tax assets, net

 8,375  8,039  7,373  7,373 

Property and equipment, net

 1,726  1,755  1,704  1,757 

Goodwill

 23,830  23,834  10,346  10,118 

Intangible assets, net

 11,735  12,804  9,483  10,505 

Operating lease right of use assets

 4,508  4,862  4,284  4,541 

Other assets

  405   392   530   394 

Total assets

 $85,058  $90,128  $61,702  $71,854 
  

LIABILITIES AND STOCKHOLDERS' EQUITY

  

Current liabilities:

  

Accounts payable

 $2,956  $2,160  $3,512  2,334 

Accrued liabilities

 10,161  14,111  7,443  12,083 

Notes payable

 267  296 

Operating lease liabilities, current portion

  896   899   983   948 

Total current liabilities

 14,280  17,466  11,938  15,365 
  

Other liabilities, noncurrent

 1,030  995  159  907 

Operating lease liabilities, noncurrent

  5,276   5,709   4,803   5,189 

Total liabilities

 20,586  24,170  16,900  21,461 
  

Stockholders' equity:

  

Preferred stock, $0.00001 par value; 5,000,000 shares authorized; none issued and outstanding

 0  0  -  - 

Common stock, $0.00001 par value; 100,000,000 shares authorized; 36,528,085 and 36,403,833 shares issued and outstanding, respectively

 0  0 
Common stock, $0.00001 par value; 100,000,000 shares authorized; 36,984,295 and 36,611,240 shares issued and outstanding, respectively - - 

Additional paid-in capital

 107,507  107,110  109,523  108,551 

Accumulated deficit

 (42,951) (41,154) (64,276) (57,366)

Accumulated other comprehensive income (loss)

  (84)  2   (445)  (792)

Total stockholders' equity

  64,472   65,958   44,802   50,393 

Total liabilities and stockholders' equity

 $85,058  $90,128  $61,702  $71,854 

 

See accompanying notes

 

1

 

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share and share amounts)

(Unaudited)

 

 

Three months ended

 

Six months ended

  

Three months ended

 

Six months ended

 
 

March 31,

 

March 31,

  

March 31,

 

March 31,

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

  

2023

  

2022

 

Revenues:

  

Product sales

 $11,854  $10,131  $21,424  $17,081  $9,940  $11,854  $19,058  $21,424 

Contract and other

  1,314   1,170   2,421   2,248   1,273   1,314   2,642   2,421 

Total revenues

 13,168  11,301  23,845  19,329  11,213  13,168  21,700  23,845 

Cost of revenues

  6,208   6,047   11,743   10,350   6,288   5,991   11,943   11,365 
  

Gross profit

  6,960   5,254   12,102   8,979   4,925   7,177   9,757   12,480 
  

Operating expenses

  

Selling, general and administrative

 5,594  3,824  10,631  7,155  6,054  5,811  12,439  11,009 

Research and development

  1,893   877   3,607   1,964   2,281   1,893   4,216   3,607 

Total operating expenses

 7,487  4,701  14,238  9,119  8,335  7,704  16,655  14,616 
  

(Loss) income from operations

 (527) 553  (2,136) (140)

Loss from operations

 (3,410) (527) (6,898) (2,136)
  

Other (loss) income, net

  (10)  (8)  3   61 

Other income (expense), net

  15   (10)  (4)  3 
  

(Loss) income before income taxes

 (537) 545  (2,133) (79)

Income tax (benefit) expense

  (45)  283   (336)  278 

Net (loss) income

 $(492) $262  $(1,797) $(357)

Loss before income taxes

 (3,395) (537) (6,902) (2,133)

Income tax expense (benefit)

  8   (45)  8   (336)

Net loss

 $(3,403) $(492) $(6,910) $(1,797)
  
  

Net (loss) income per common share - basic

 $(0.01) $0.01  $(0.05) $(0.01)

Diluted

 $(0.01) $0.01  $(0.05) $(0.01)

Net loss per common share - basic and diluted

 $(0.09) $(0.01) $(0.19) $(0.05)
 

Weighted average common shares outstanding:

  

Basic

  36,353,321   33,683,240   36,405,321   33,629,479 

Diluted

  36,353,321   34,779,266   36,405,321   33,629,479 

Basic and diluted

  36,817,026   36,353,321   36,755,920   36,405,321 

\

See accompanying notes

 

2

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE (LOSS) INCOMELOSS

(in thousands)

(Unaudited)

 

  

Three months ended

  

Six months ended

 
  

March 31,

  

March 31,

 
  

2022

  

2021

  

2022

  

2021

 

Net (loss) income

 $(492) $262  $(1,797) $(357)

Other comprehensive (loss) income

                

Unrealized loss on marketable securities

  (59)  (3)  (69)  (6)

Unrealized foreign currency gain (loss)

  58   (75)  (17)  397 

Comprehensive (loss) income

 $(493) $184  $(1,883) $34 
  

Three months ended

  

Six months ended

 
  

March 31,

  

March 31,

 
  

2023

  

2022

  

2023

  

2022

 

Other comprehensive loss

 $(3,403) $(492) $(6,910) $(1,797)

Unrealized gain (loss) on marketable securities

  29   (59)  50   (69)

Unrealized foreign currency gain (loss)

  52   58   297   (17)

Comprehensive loss

 $(3,322) $(493) $(6,563) $(1,883)

See accompanying notes

 

3

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

 

Six Months Ended

  

Six Months Ended

 

 

March 31,

 
` 

March 31,

 
 

2022

  

2021

  

2023

  

2022

 

Operating Activities:

  

Net loss

 $(1,797) $(357) $(6,910) $(1,797)
  

Adjustments to reconcile net income to net cash provided by operating activities:

  

Depreciation and amortization

 1,282  552  1,282  1,282 

Amortization of debt issuance costs

 10  2  8  10 

Warranty provision

 16  37  52  16 

Inventory obsolescence

 64  196  90  64 

Stock-based compensation

 1,295  510  933  1,295 

Realized loss on foreign currency forward contract

 0  (76)

Deferred income taxes

 (336) 278  -  (336)

Amortization of operating lease right of use asset

 360  343  385  360 

Accretion of acquisition holdback liability

 24  22  24  24 
  

Changes in operating assets and liabilities:

  

Accounts receivable, net

 2,123  (14) 3,158  2,123 

Inventories, net

 (3,291) (698) (3,469) (3,291)

Prepaid expenses and other

 750  (253) 1,840  750 

Accounts payable

 805  1,184  1,145  805 

Accrued and other liabilities

  (4,412)  (1,363)  (6,004)  (4,412)

Net cash (used in) provided by operating activities

  (3,107)  363 

Net cash used in operating activities

  (7,466)  (3,107)
  

Investing Activities:

  

Purchases of marketable securities

 (3,656) (2,799) (3,641) (3,656)

Proceeds from maturities of marketable securities

 3,681  2,939  4,716  3,681 

Cash paid for acquisitions net of cash acquired

 0  (4,367)

Capital expenditures

  (171)  (148)  (157)  (171)

Net cash used in investing activities

  (146)  (4,375)

Net cash provided by (used in) investing activities

  918   (146)
  

Financing Activities:

  

Proceeds from exercise of stock options

 170  170  86  170 

Repurchase of common stock

 (998) 0  -  (998)

Shares retained for payment of taxes in connection with settlement of restricted stock units

 (70) (141) (45) (70)

Payments on promissory notes

 (17) (18)  -   (17)

Cash paid for debt issuance costs

  0   (38)

Net cash used in financing activities

  (915)  (27)

Net cash provided by (used in) financing activities

  41   (915)

Effect of foreign exchange rate on cash

  (20)  (30)  54   (20)

Net decrease in cash, cash equivalents, and restricted cash

 (4,188) (4,069) (6,453) (4,188)

Cash, cash equivalents and restricted cash, beginning of period

  14,528   23,996   13,659   14,528 

Cash, cash equivalents and restricted cash, end of period

 $10,340  $19,927  $7,206  $10,340 
 

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:

 

Cash and cash equivalents

 $8,977  $18,455 

Restricted cash, current portion

 267  282 

Long-term restricted cash

  1,096   1,190 

Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows

 $10,340  $19,927 

Reconciliation of cash, cash equivalents and restricted cash to the consolidated balance sheets:

        

Cash and cash equivalents

 $6,371  $8,977 

Restricted cash, current portion

  739   267 

Long-term restricted cash

  96   1,096 

Total cash, cash equivalents and restricted cash shown in the consolidated statement of cash flows

 $7,206  $10,340 

 

See accompanying notes

 

4

 

Genasys Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (continued)

(in thousands)

(Unaudited)

 

 

Six Months Ended

  

Six Months Ended

 
 

March 31,

  

March 31,

 
 

2022

  

2021

  

2023

  

2022

 

Noncash investing and financing activities:

  

Change in unrealized loss on marketable securities

 $(69) $(6) $50  $(69)

Obligation to issue common stock in connection with the Amika Mobile asset purchase

 $(832) $(3,431) $(416) $(832)

Initial measurement of operating lease right of use assets

 $7  $(259) $79  $7 

Initial measurement of operating lease liabilities

 $7  $(259) $79  $7 
 

Business combinations accounted for as a purchase

 

Fair value of net assets acquired

 $0  $613 

 

5

 

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

1. OPERATIONS

Genasys Inc. (the “Company”) is a global provider of critical communications hardwaresoftware solutions and softwarehardware systems designed to alert, inform, and protect.protect communities and organizations. The Company'sGenasys Protect™ unified platform receivescollects information on developing and active emergency situations from a wide variety of sensors and Internet-of-Things (IoT) inputs and empowers governments, businesses, and organizations to collectdeliver real-time, information on developinggeo-targeted notifications and active emergency situations. The Company uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channelspeople in harm’s way before, during, and after public safety and enterprise threats, critical events, and other crisis situations.threats.

 

 

2. BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

General

 

The Company’s unaudited interim condensed consolidated financial statements included herein have been prepared in accordance with the instructions to Form 10-Q10-Q and Article 8 of Regulation S-XS-X and the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been condensed or omitted pursuant to such rules and regulations. In management’s opinion, the accompanying financial statements reflect adjustments necessary to present fairly the financial position, results of operations, and cash flows for those periods indicated, and contain adequate disclosure to make the information presented not misleading. Adjustments included herein are of a normal, recurring nature unless otherwise disclosed in the footnotes. The condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and notes thereto for the year ended September 30,2021, 2022, included in the Company’s Annual Report on Form 10-K,10-K, as filed with the SEC on November 23, 2021. December 16, 2022. The accompanying condensed consolidated balance sheet as of September 30, 2021 2022, has been derived from the audited consolidated balance sheet as of September 30, 2021 2022, contained in the above referenced Form 10-K.10-K. Results of operations for interim periods are not necessarily indicative of the results of operations for a full year.

 

Principles of consolidation

 

The Company has eight wholly owned subsidiaries, Genasys II Spain, S.A.U. (“Genasys Spain”), Genasys Communications Canada ULC (“Genasys Canada”), Genasys Singapore PTE Ltd, Genasys Puerto Rico, LLC, Zonehaven LLC, and Genasys Inc. (branch) in the United Arab Emirates and two currently inactive subsidiaries, Genasys America de CV and LRAD International Corporation. The consolidated financial statements include the accounts of these subsidiaries after elimination of intercompany transactions and accounts.

 

Cash, cash equivalents and restricted cash

 

The Company considers all highly liquid investments with an original maturity of three months or less, when purchased, to be cash equivalents. As of March 31, 2022, 2023, the amount of cash and cash equivalents was $8,977.$6,371. As of September 30, 2021, 2022, the amount of cash and cash equivalents was $13,167.$12,736.

 

The Company considers any amounts pledged as collateral or otherwise restricted for use in current operations to be restricted cash. In addition, the Company excludes from cash and cash equivalents cash required to fund specific future contractual obligations related to business combinations. Restricted cash is classified as a current asset unless amounts are not expected to be released and available for use in operations within one year. As of March 31, 2022, 2023, the current portion of restricted cash was $267,$739, and the noncurrent portion was $1,096.$96. As of September 30, 2021, 2022, the current portion of restricted cash was $279,$100, and the noncurrent portion was $1,082.$823.

 

Reclassifications

 

Where necessary, certain prior year’s information has been reclassified to conform to the current year presentation.

 

 

3. RECENT ACCOUNTING PRONOUNCEMENTS

 

New pronouncements pending adoption

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No.2016-13, 2016-13, Measurement of Credit Losses on Financial Instruments, which supersedes current guidance by requiring recognition of credit losses when it is probable that a loss has been incurred. The new standard requires the establishment of an allowance for estimated credit losses on financial assets including trade and other receivables at each reporting date. The new standard will result in earlier recognition of allowances for losses on trade and other receivables and other contractual rights to receive cash. In November 2019, the FASB issued ASU No.2019-10, 2019-10, Financial Instruments Credit Losses (ASC 326)326), Derivatives and Hedging (ASC 815)815) and Leases (ASC 842)842), which extends the effective date of ASC 326 for certain companies until fiscal years beginning after December 15, 2022. The new standard will be effective for the Company in the first quarter of fiscal year beginning October 1, 2023, and early adoption is permitted. The Company has not completed its review of the impact of this standard on its consolidated financial statements. However, based on the Company’s history of immaterial credit losses from trade receivables, the Company does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

6

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

In March 2020, the FASB issued ASU No.2020-04, 2020-04, Reference Rate Reform (ASC 848)848), Facilitation of the Effects of Reference Rate Reform on Financial Reporting. ASU No.2020-04 2020-04 provides optional guidance, expedients and exceptions for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. The amendments in this update apply to all entities, subject to meeting the criteria, which participate in contracts, hedging relationships and other transactions that reference LIBOR or another reference rate expected to be discontinued because of reference rate reform. ASU No.2020-04 2020-04 was subsequently amended by ASU No.2021-01, 2021-01, Reference Rate Reform (ASC 848)848), Scope, which refines the scope of ASC 848 and permits optional expedients and exceptions when accounting for derivative contracts and certain hedging relationships. The amendments of these updates arewere available to all entities as of March 12, 2020 2020. In December 2022, the FASB issued ASU 2022-06, Reference Rate Reform (ASC 848), Deferral of the Sunset Date of Topic 848, extending the relief offered in this series of ASUs through December 31, 2022. 2024. The Company intends to adopt this standard when LIBOR is discontinued. The Company does not expect that the adoption of this standard will have a material effect on the Company’s consolidated financial statements.

 

 

4. REVENUE RECOGNITON

REVENUE RECOGNITION

 

ASC 606,Revenue from Contracts with Customers (“ASC 606”), outlines a new, single comprehensive model for entities to use in accounting for revenue arising from contracts with customers and supersedes most revenue recognition guidance, including industry-specific guidance. This new revenue recognition model provides a five-stepfive-step analysis in determining when and how revenue is recognized:

 

 

1.

Identify the contract(s) with customers

 

2.

Identify the performance obligations

 

3.

Determine the transaction price

 

4.

Allocate the transaction price to the performance obligations

 

5.

Recognize revenue when the performance obligations have been satisfied

 

ASC 606 requires revenue recognition to depict the transfer of promised goods or services to customers in an amount that reflects the consideration a company expects to receive in exchange for those goods or services.

 

The Company derives its revenue from the sale of products to customers, contracts, software license fees, other services and freight. The Company sells its products through its direct sales force and through authorized resellers and system integrators. The Company recognizes revenue for goods including software when all the significant risks and rewards have been transferred to the customer, no continuing managerial involvement usually associated with ownership of the goods is retained, no effective control over the goods sold is retained, the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transactions will flow to the Company and the costs incurred or to be incurred in respect of the transaction can be measured reliably. Software license revenue, maintenance and/or software development service fees may be bundled in one arrangement or may be sold separately.

 

Product revenue

 

Product revenue is recognized as a distinct single performance obligation when products are tendered to a carrier for delivery, which represents the point in time that the Company’s customer obtains control of the products. A smaller portion of product revenue is recognized when the customer receives delivery of the products. A portion of products are sold through resellers and system integrators based on firm commitments from an end user, and as a result, resellers and system integrators carry little or no inventory. The Company’s customers do not have a right to return product unless the product is found defective and therefore the Company’s estimate for returns has historically been insignificantinsignificant.

 

Perpetual licensed software

 

The sale and/or license of software products is deemed to have occurred when a customer either has taken possession of, or has the ability to take immediate possession of, the software and the software key. Perpetual software licenses can include one-yearone-year maintenance and support services. In addition, the Company sells maintenance services on a stand-alone basis and is therefore capable of determining their fair value. On this basis, the amount of the embedded maintenance is separated from the fee for the perpetual license and is recognized on a straight-line basis over the period to which the maintenance relates.

 

7

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Time-based licensed software

 

The time-based license agreements include the use of a software license for a fixed term, generally one-year,one-year, and maintenance and support services during the same period. The Company does not sell time-based licenses without maintenance and support services and therefore revenues for the entire arrangements are recognized on a straight-line basis over the term.

7

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

Warranty, maintenance, and services

 

The Company offers extended warranty, maintenance and other services. Extended warranty and maintenance contracts are offered with terms ranging from one to several years, which provide repair and maintenance services after expiration of the original one-yearone-year warranty term. Revenues from separately priced extended warranty and maintenance contracts are recognized based on time elapsed over the service period and classified as contract and other revenues. Revenue from other services such as training or installation is recognized when the service is completed.

 

Multiple element arrangements

 

The Company has entered into a number of multiple element arrangements, such as the sale of a product or perpetual licenses that may include maintenance and support (included in the price of perpetual licenses) and time-based licenses (that include embedded maintenance and support, both of which may be sold with software development services, training, and other product sales). In some cases, the Company delivers software development services bundled with the sale of the software. In multiple element arrangements, the Company uses either the stand-alone selling price or an expected cost pluscost-plus margin approach to determine the fair value of each element within the arrangement, including software and software-related services such as maintenance and support. In general, elements in such arrangements are also sold on a stand-alone basis and stand-alone selling prices are available.

 

Revenue is allocated to each deliverable based on the fair value of each individual element and is recognized when the revenue recognition criteria described above are met, except for time-based licenses which are not unbundled. When software development services are performed and are considered essential to the functionality of the software, the Company recognizes revenue from the software development services on a stage of completion basis, and the revenue from the software when the related development services have been completed.

 

The Company disaggregates revenue by reporting segment (Hardware and Software) and geographically to depict the nature of revenue in a manner consistent with its business operations and to be consistent with other communications and public filings. Refer to Note 18, Segment Information and Note 19, Major Customers, Suppliers and Related Information for additional details of revenues by reporting segment and disaggregation of revenue.

 

Contract assets and liabilities

 

The Company enters into contracts to sell products and provide services and recognizes contract assets and liabilities that arise from these transactions. The Company recognizes revenue and corresponding accounts receivable according to ASC 606 and, at times, recognizes revenue in advance of the time when contracts give the Company the right to invoice a customer. Sales commissions are considered incremental and recoverable costs of obtaining a contract with a customer. Subscription related commission costs are deferred and then amortized on a straight-line basis over the period of benefit. The Company may also receive consideration, per terms of a contract, from customers prior to transferring goods to the customer. The Company records customer deposits as a contract liability. Additionally, the Company may receive payments, most typically for service and warranty contracts, at the onset of the contract and before the services have been performed. In such instances, a deferred revenue liability is recorded. The Company recognizes these contract liabilities as revenue after all revenue recognition criteria are met. The table below reflects the balances of contract liabilities as of March 31, 2022 2023, and September 30, 2021, 2022, including the change between the periods. There were 0no contract assets as of March 31, 2022 2023, and September 30, 2021. 2022. The current portion of contract liabilities and the non-currentnoncurrent portion are included in “Accrued liabilities” and “Other liabilities, noncurrent”, respectively, on the accompanying condensed consolidated balance sheets. Refer to Note 10, Accrued and Other Liabilities for additional details.

 

8

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

The Company’s contract liabilities were as follows:

 

 

Customer

deposits

 

Deferred

revenue

 

Total contract

liabilities

  

Customer

deposits

 

Deferred

revenue

 

Total

contract

liabilities

 

Balance as of September 30, 2021

 $8,701  $1,428  $10,129 

Balance as of September 30, 2022

 $4,724  $2,054  $6,778 

New performance obligations

 4,298  801  5,099  4,831  1,215  6,046 

Recognition of revenue as a result of satisfying performance obligations

 (7,259) (941) (8,200) (7,701) (1,489) (9,190)

Effect of exchange rate on deferred revenue

  0  1  1   1  31  32 

Balance as of March 31, 2022

 $5,740  $1,289  $7,029 

Balance as of March 31, 2023

 $1,855  $1,811  $3,666 

Less: non-current portion

  0  (307) (307)  -  (159) (159)

Current portion as of March 31, 2022

 $5,740  $982  $6,722 

Current portion as of March 31, 2023

 $1,855  $1,652  $3,507 

8

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

Remaining performance obligations

 

Remaining performance obligations related to ASC 606 represent the aggregate transaction price allocated to performance obligations under an original contract with a term greater than one year, which are fully or partially unsatisfied at the end of the period.

 

As of March 31, 2022, 2023, the aggregate amount of the transaction price allocated to remaining performance obligations was approximately $7,029.$3,666. The Company expects to recognize revenue on approximately $6,722$3,507 or 96% of the remaining performance obligations over the next 12 months, and the remainder is expected to be recognized thereafter.

 

Practical expedients

 

In cases where the Company is responsible for shipping after the customer has obtained control of the goods, the Company has elected to treat these activities as fulfillment activities rather than as a separate performance obligation. Additionally, the Company has elected to capitalize the cost to obtain a contract only if the period of amortization would be longer than one year. The Company only gives consideration to whether a customer agreement has a financing component if the period of time between transfer of goods and services and customer payment is greater than one year. The Company also utilizes the “as invoiced” practical expedient in certain cases where performance obligations are satisfied over time and the invoiced amount corresponds directly with the value the Company is providing to the customer.

 

 

5. FAIR VALUE MEASUREMENTS

FAIR VALUE MEASUREMENTS

 

The Company’s financial instruments consist principally of cash equivalents, short and long-term marketable securities, accounts receivable, and accounts payable. The fair value of a financial instrument is the amount that would be received in an asset sale or paid to transfer a liability in an orderly transaction between unaffiliated market participants. Assets and liabilities measured at fair value are categorized based on whether or not the inputs are observable in the market and the degree that the inputs are observable. The categorization of financial instruments within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. The hierarchy is prioritized into three levels (with Level 3 being the lowest) defined as follows:

 

 

Level 1:

Inputs are based on quoted market prices for identical assets or liabilities in active markets at the measurement date.

 

Level 2:

Inputs include quoted prices for similar assets or liabilities in active markets and/or quoted prices for identical or similar assets or liabilities in markets that are not active near the measurement date.

 

Level 3:

Inputs include management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. The inputs are unobservable in the market and significant to the instrument’s valuation.

 

The fair value of the Company’s cash equivalents and marketable securities were determined based on Level 1 and Level 2 inputs. The valuation techniques used to measure the fair value of the “Level 2” instruments were based on quoted market prices or model-driven valuations using significant inputs derived from or corroborated by observable market data. The Company believes that the recorded values of its other financial instruments approximate their current fair values because of their nature and respective relatively short maturity dates or durations. The Company did not have any marketable securities in the Level 3 category as of March 31, 2022 2023, or September 30, 2021. 2022. There have been no changes in Level 1, Level 2, and Level 3 and no changes in valuation techniques for financial instruments measured at fair value on a recurring basis for the periods ended March 31, 2022 2023, and September 30, 2021.2022.

 

9

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Instruments measured at fair value on a recurring basis

 

Cash equivalents and marketable securities: The following tables present the Company’s cash equivalents and marketable securities’ costs, gross unrealized gains and losses, and fair value by major security type recorded as cash equivalents or short-term or long-term marketable securities as of March 31, 2022 2023, and September 30, 2021. 2022. Unrealized gains and losses from the remeasurement of marketable securities are recorded in accumulated other comprehensive income (loss) until recognized in earnings upon the sale or maturity of the security.

 

 

March 31, 2022

  

March 31, 2023

 
 

Cost Basis

  

Unrealized
Gain (Loss)

  

Fair Value

  

Cash
Equivalents

  

Short-term
Securities

  

Long-term
Securities

  

Cost Basis

  

Unrealized

Loss

  

Fair Value

  

Cash

Equivalents

  

Short-term

Securities

  

Long-term

Securities

 

Level 1:

  

Money market funds

 $988  $0  $988  $988  $-  $-  $510  $-  $510  $510  $-  $- 
  

Level 2:

  

Certificates of deposit

 1,244  0  1,244  0  942  302  302  -  302  -  -  302 

Municipal securities

 5,370  (48) 5,322  0  4,126  1,196  3,694  (28) 3,666  -  3,367  299 

Corporate bonds

  923   (21)  902   0   136   766   2,197   (12)  2,185   -   2,185   - 

Subtotal

  7,537   (69)  7,468   0   5,204   2,264   6,193   (40)  6,153   -   5,552   601 
                          

Total

 $8,525  $(69) $8,456  $988  $5,204  $2,264  $6,703  $(40) $6,663  $510  $5,552  $601 

 

  

September 30, 2021

 
  

Cost Basis

  

Unrealized
Gain (Loss)

  

Fair Value

  

Cash
Equivalents

  

Short-term
Securities

  

Long-term
Securities

 

Level 1:

                        

Money market funds

 $932  $0  $932  $932  $-  $- 
                         

Level 2:

                        

Certificates of deposit

  1,494   0   1,494   0   694   800 

Municipal securities

  5,139   (1)  5,138   0   4,205   933 

Corporate bonds

  928   1   929   0   787   142 

Subtotal

  7,561   0   7,561   0   5,686   1,875 
                         

Total

 $8,493  $0  $8,493  $932  $5,686  $1,875 

  

September 30, 2022

 
  

Cost Basis

  

Unrealized

Loss

  

Fair Value

  

Cash

Equivalents

  

Short-term

Securities

  

Long-term

Securities

 
Level 1:                        

Money market funds

 $1,316  $-  $1,316  $1,316  $-  $- 
                         
Level 2:                        

Certificates of deposit

  800   -   800   -   498   302 

Municipal securities

  4,066   (65)  4,001   -   3,772   229 

Corporate bonds

  2,402   (25)  2,377   -   2,127   250 

Subtotal

  7,268   (90)  7,178   -   6,397   781 
                         

Total

 $8,584  $(90) $8,494  $1,316  $6,397  $781 

 

Instruments measured at fair value on a non-recurring basis

 

Nonfinancial assets: Nonfinancial assets such as goodwill, other intangible assets, long-lived assets held and used, and right-of-use (“ROU”) assets are measured at fair value when there is an indicator of impairment and recorded at fair value only when impairment is recognized or for a business combination. 

 

Goodwill and intangible assets are recognized at fair value during the period in which an acquisition is completed, from updated estimates during the measurement period, or when they are considered to be impaired. These non-recurring fair value measurements, primarily for intangible assets acquired, were based on Level 3 inputs. The Company estimates the fair value of these long-lived assets on a non-recurring basis based on a market valuation approach, engaging independent valuation experts to assist in the determination of fair value.

 

The following table presents nonfinancial assets that were subject to fair value measurement during the six months ended March 31, 2022. Certain intangible assets, operating lease ROU assets and goodwill are subject to foreign currency translation adjustments. There were no business combinations or indicators of impairment for the six months ended March 31, 2022.

  

Carrying

Value

  

Level 1

  

Level 2

  

Level 3

  

Gain/ (Loss)

 

Operating lease ROU asset

 $7  $0  $0   7  $0 

10

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Holdback Liability: In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities, misrepresentations and indemnifications against third-partythird-party claims. Adjustments of up to CAD$CAD$1,000 ((USD$USD$799739) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The holdback liability was recorded at the present value which was the fair value at the acquisition date. The Company engaged independent valuation experts to assist in determining the present value of the holdback liability. The expected future payment was discounted using a rate representative of the Company’s payment risk and credit rating. Accretion is recorded in each subsequent reporting period based on the discount factor used to arrive at the original fair value. This change in fair value is recorded in the accompanying condensed consolidated statement of operations. The changes in the carrying amount of the holdback liability is as follows:

 

Balance as of September 30, 2021

 $687 

Balance as of September 30, 2022

 $680 

Accretion

 24  24 

Currency translation

  12   10 

Balance as of March 31, 2022

 $723 

Balance as of March 31, 2023

 $714 

10

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

 

6. INVENTORIES, NET

INVENTORIES, NET

 

Inventories, net consisted of the following:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Raw materials

 $8,280  $5,449  $7,229  $5,277 

Finished goods

 723  842  867  844 

Work in process

  1,381   877  2,063  744 

Inventories, gross

 10,384  7,168  10,159  6,865 

Reserve for obsolescence

  (742)  (752) (772) (857)

Inventories, net

 $9,642  $6,416  $9,387  $6,008 

 

 

7. PROPERTY AND EQUIPMENT, NET

PROPERTY AND EQUIPMENT, NET

 

Property and equipment, net consisted of the following:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Office furniture and equipment

 $1,355  $1,261  $1,577  $1,432 

Machinery and equipment

 1,380  1,270  1,425  1,391 

Leasehold improvements

  2,173   2,154  2,302  2,172 

Construction in progress

  -   104 

Property and equipment, gross

 4,908  4,685  5,304  5,099 

Accumulated depreciation

  (3,182)  (2,930)  (3,600)  (3,342)

Property and equipment, net

 $1,726  $1,755  $1,704  $1,757 

 

Depreciation and amortization expense for property and equipment was $102$113 and $101$102 for the three months ended March 31, 2023 and 2022, respectively. Depreciation and 2021, respectively,amortization expense for property and equipment was $224 and $199 and $200 for the six months ended March 31, 2023 and 2022, and 2021,respectively.

 

 

8. GOODWILL AND INTANGIBLE ASSETS

GOODWILL AND INTANGIBLE ASSETS

 

Goodwill is attributable to the acquisitions of Genasys Spain and Zonehaven, and the Amika Mobile asset purchase and is due to combining the integrated emergency critical communications, mass messaging solutions, and software development capabilities with existing hardware products for enhanced offerings and the skill level of the acquired workforces. The Company periodically reviews goodwill for impairment in accordance with relevant accounting standards.

There were no additions In the fourth quarter of fiscal 2022, in conjunction with the annual impairment assessment, the Company determined that the fair value of the software reporting unit was less than the carrying value. The Company engaged independent valuation experts to assist in determining the fair value of the software reporting unit and recorded a $13,162 goodwill during the six months ended impairment charge. As of March 31, 2022. During the year ended 2023, and September 30, 2021, the Company added a total of $21,128 in goodwill related to the Zonehaven acquisition and the Amika Mobile asset purchase. As of March 31, 2022, and September 30, 2021, goodwill was $23,830$10,346 and $23,834,$10,118 respectively. There were 0no additions or impairments to goodwill during the six months ended March 31, 2022.2023.

 

11

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

The changes in the carrying amount of goodwill by segment for the six months ended March 31, 2022, 2023, were as follows:

 

  

Hardware

  

Software

  

Total

 

Balance as of September 30, 2021

 $0  $23,834  $23,834 

Currency translation

  0   (4)  (4)

Balance as of March 31, 2022

 $0  $23,830  $23,830 
  

Hardware

  

Software

  

Total

 

Balance as of September 30, 2022

 $-  $10,118  $10,118 

Currency translation

  -   228   228 

Balance as of March 31, 2023

 $-  $10,346  $10,346 

 

Intangible assets and goodwill related to Genasys Spain are translated from Euros to U.S. dollars at the balance sheet date. The net impact of foreign currency exchange differences arising during the period related to goodwill and intangible assets was a decrease of $125. Intangible assets and goodwill related to Amika Mobile are translated from Canadian dollars to U.S. dollars at the balance sheet date. The net impact of foreign currency exchange differences arising during the period related to goodwill and intangible assets was an increase of $135.$264.

11

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

The changes in the carrying amount of intangible assets by segment for the six months ended March 31, 2022, 2023, were as follows:

 

 

Hardware

  

Software

  

Total

  

Hardware

  

Software

  

Total

 

Balance as of September 30, 2021

 $25  $12,779  $12,804 

Balance as of September 30, 2022

 $21  $10,484  $10,505 

Amortization

 (2) (1,081) (1,083) (2) (1,056) (1,058)

Currency translation

  0   14   14   -   36   36 

Balance as of March 31, 2022

 $23  $11,712  $11,735 

Balance as of March 31, 2023

 $19  $9,464  $9,483 

 

The Company’s consolidated intangible assets consisted of the following:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Technology

 $12,081  $12,065  $11,947  $11,886 

Customer relationships

 1,835  1,855  1,806  1,715 

Trade name portfolio

 616  625  611  590 

Non-compete agreements

 234  244  229  206 

Patents

  72   72  72  72 
 14,838  14,861  14,665  14,469 

Accumulated amortization

  (3,103)  (2,057) (5,182) (3,964)
 $11,735  $12,804  $9,483  $10,505 

 

As of March 31, 2022, 2023, future amortization expense is as follows:

 

Fiscal year ending September 30,

  

2022 (remaining six months)

 1,083 

2023

 2,135 

2023 (remaining six months)

 $1,050 

2024

 2,122  2,099 

2025

 1,999  1,979 

2026

 1,863  1,842 

2027

 1,669 

Thereafter

  2,533   844 

Total estimated amortization expense

 $11,735  $9,483 

 

Amortization expense was $541$526 and $169$541 for the three months ended March 31, 2023 and 2022, and 2021, respectively,respectively. Amortization expense was $1,058 and $1,083 and $352 for the six months ended March 31, 2023 and 2022, and 2021,respectively.

12

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

 

9. PREPAID EXPENSES AND OTHER

 

Prepaid expenses and other current assets consisted of the following:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Deposits for inventory

 $201  $997  $101  $461 

Prepaid insurance

 473  395  270  360 

Dues and subscriptions

 233  213  271  182 

Prepaid professional services

 79  158 

Prepaid commissions

 159  82  387  228 

Trade shows and travel

 143  95  211  471 

Canadian goods and services and harmonized sales tax receivable

 115  1,631 

Other

  191   315   258   244 
 $1,479  $2,255  $1,613  $3,577 

 

Deposits for inventory

 

Deposits for inventory consisted of cash payments to vendors for inventory to be delivered in the future.

12

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

Prepaid insurance

 

Prepaid insurance consisted of premiums paid for health, commercial and corporate insurance. These premiums are amortized on a straight-line basis over the term of the agreements.

 

Dues and subscriptions

 

Dues and subscriptions consisted of payments made in advance for software subscriptions and trade and professional organizations. These payments are amortized on a straight-line basis over the term of the agreements.

Prepaid professional services

Prepaid professional services consisted of payments made in advance for services such as accounting and legal services.

 

Prepaid commissions

 

Prepaid commissions represented the current portion of sales commissions paid in connection with obtaining a contract with a customer. These costs are deferred and are amortized on a straight-line basis over the period of benefit, which is typically between three and five years. Amortization of prepaid commissions is included in selling, general and administrative expenses in the accompanying condensed consolidated statement of operations.

 

Trade shows and travel

 

Trade shows and travel consisted of payments made in advance for trade show events.

 

13

Canadian goods and services and harmonized sales tax receivable

 

Genasys Inc.

NotesThe goods and services tax and harmonized sales tax (“GST/HST”) is a Canadian value-added tax that applies to many goods and services. Registrants may claim refundable tax credits for GST/HST incurred through filing periodic tax returns. This GST/HST receivable is a receivable from the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Canadian Revenue Agency.

 

 

10. ACCRUED AND OTHER LIABILITIES

 

Accrued liabilities consisted of the following:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Payroll and related

 $2,477  $3,726  $2,422  $3,003 

Deferred revenue

 982  1,120  1,652  1,827 

Customer deposits

 5,740  8,701  1,855  4,724 

Accrued contract costs

 710  416  622  809 

Warranty reserve

 150  146  150  159 

Canadian goods and services and harmonized sales tax payable

 -  1,556 

Asset purchase holdback liability

 714  - 

Other

  102   2   28   5 

Total

 $10,161  $14,111  $7,443  $12,083 

 

Other liabilities-noncurrent consisted of the following:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Deferred extended warranty revenue

 $307  $308 

Deferred revenue

 $159  $227 

Asset purchase holdback liability

  723   687   -   680 

Total

 $1,030  $995  $159  $907 

 

Payroll and related

 

Payroll and related consisted primarily of accrued vacation, bonus, sales commissions and benefits.

 

Deferred revenue

 

Deferred revenue as of March 31, 2022, 2023, included prepayments from customers for services, including extended warranty, scheduled to be performed in the twelve months ending March 31, 2023.2024.

 

Customer deposits

 

Customer deposits represent amounts paid by customers as a down payment on hardware orders to be delivered in the twelve months ending March 31, 2023.2024.

13

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

Accrued contract costs

 

Accrued contract costs consisted of accrued expenses for contracting a third-partythird-party service provider to fulfill repair and maintenance obligations required under a contract with a foreign military for units sold in the year ended September 30, 2011. Payments to the service provider will be made annually upon completion of each year of service. A new contract was signed with the customer in May 2019 to continue repair and maintenance services through May 2024. These services are being recorded in cost of revenues to correspond with the revenues for these services.

Asset purchase holdback liability

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities, misrepresentations and indemnifications against third-party claims. Adjustments of up to CAD$1,000 (USD$739) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

Warranty reserve

 

Changes in the warranty reserve and extended warranty were as follows:

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

Beginning balance

 $146  $126  $159  $146 

Warranty provision

 16  56  52  86 

Warranty settlements

  (12)  (36)  (61)  (73)

Ending balance

 $150  $146  $150  $159 

 

The Company establishes a warranty reserve based on anticipated warranty claims at the time product revenue is recognized. Factors affecting warranty reserve levels include the number of units sold, anticipated cost of warranty repairs and anticipated rates of warranty claims. The Company evaluates the adequacy of the provision for warranty costs each reporting period and adjusts the accrued warranty liability to an amount equal to estimated warranty expense for products currently under warranty.

 

14

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Deferred extended warranty revenue

 

Deferred extended warranty revenue consisted of warranties purchased in excess of the Company’s standard warranty. Extended warranties typically range from one to two years.

Asset purchase holdback liability

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities, misrepresentations and indemnifications against third-party claims. Adjustments of up to CAD$1,000 (USD$799) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

 

11. DEBT

In connection with the acquisition of Genasys Spain the Company acquired certain debts of Genasys Spain. The carrying value of the acquired debt approximates fair value. The balances of the acquired debt consist of loans with governmental agencies as of March 31, 2022. Loans with governmental agencies represent interest free debt granted by ministries within Spain for the purpose of stimulating economic development and promoting research and development. Loans with governmental agencies as of March 31, 2022 are as follows:

  

Principal

 

Loans with governmental agencies, current portion

 $267 (a)

(a)

This loan is secured by $267 of cash pledged as collateral by Genasys Spain, which is the current balance of the loan. This amount is included in restricted cash as of March 31, 2022.  In April 2022, the Ministry of Economy and Competitiveness declared the terms of the loan satisfied and the outstanding balance of the loan was paid in full with the restricted cash. Accordingly, this has been included in the current portion of notes payable as of March 31, 2022.

The changes in the carrying amount of debt for the six months ended March 31, 2022, are as follows:

Balance as of September 30, 2021

 $296 

Payments

  (17)

Currency translation

  (12)

Balance as of March 31, 2022

 $267 

 

Revolving line of credit

 

On March 8, 2021, the Company entered into an agreement with MUFG Union Bank, N.A. for a $10 million revolving line of credit. Outstanding balances on the revolving line of credit bearbore interest at a per annum rate equal to the London Interbank Offered Rate (“LIBOR”) plus 2.25%. The agreement containscontained a provision for determining an alternative interest rate index in the event the LIBOR rate is no longer available. The agreement containscontained standard covenants, including affirmative financial covenants, such as the maintenance of a short-term liquidity ratio and a senior leverage ratio, in addition to negative covenants which limit the incurrence of additional indebtedness, loans and equity investments, disposition of assets, mergers and consolidations and other matters customarily restricted in such agreements. The maturity date of this revolving line of credit is was March 31, 2023. As of March 31, 2023, and September 30, 2022, there were 0no borrowings on the revolving line of credit. The Company incurred and capitalized $38 of issuance costs related to this revolving line of credit. These issuance costs were recorded in prepaid expenses and other assets in the condensed consolidated balance sheet and have and will bewere amortized on a straight-line basis over the term of the loan.

 

 

12. LEASES

 

The Company determines if an arrangement is a lease at inception. The guidance in ASC 842 defines a lease as a contract, or part of a contract, that conveys the right to control the use of identified property, plant, or equipment (an identified asset) for a period of time in exchange for consideration. Operating lease ROU assets and lease liabilities are recognized based on the present value of future minimum lease payments over the lease term at commencement date. The Company’s leases do not provide an implicit rate. The Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of future payments. Additionally, the portfolio approach is used in determining the discount rate used to present value lease payments. The ROU asset includes any lease payments made and excludes lease incentives and initial direct costs incurred.

 

1514

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

The Company is party to operating leases for office and production facilities and equipment under agreements that expire at various dates through 2028. The Company elected the package of practical expedients permitted under the new lease standard. In electing the practical expedient package, the Company is not required to reassess whether an existing or expired contract is or contains a lease, reassess the lease classification for expired or existing leases nor reassess the initial direct costs for leases that commenced before the adoption of ASC 842. The Company also elected the short-term lease exemption such that the new lease standard was applied to leases greater than one year in duration. Leases with an initial term of twelve months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the lease term.

 

During the six months ended March 31, 2022, the Company added an additional operating lease ROU asset of $7 and operating lease liabilities of $7 for office equipment. The tables below show the operating lease ROU assets and liabilities as of September 30, 2021, 2022, and the balances as of March 31, 2022, 2023, including the changes during the periods.

 

 

Operating lease ROU assets

  

Operating lease

ROU assets

 

Operating lease ROU assets as of September 30, 2021

 $4,862 

Operating lease ROU assets as of September 30, 2022

 $4,541 

Additional operating lease ROU assets

 7  79 

Less amortization of operating lease ROU assets

 (360) (385)

Effect of exchange rate on operating lease ROU assets

  (1)  49 

Operating lease ROU assets as of March 31, 2022

 $4,508 

Operating lease ROU assets as of March 31, 2023

 $4,284 

 

 

Operating lease liabilities

  

Operating lease

liabilities

 

Operating lease liabilities as of September 30, 2021

 $6,608 

Operating lease liabilities as of September 30, 2022

 $6,137 

Additional operating lease liabilities

 7  79 

Less lease principal payments on operating lease liabilities

 (442) (480)

Effect of exchange rate on operating lease liabilities

  (1)  50 

Operating lease liabilities as of March 31, 2022

 6,172 

Operating lease liabilities as of March 31, 2023

 5,786 

Less non-current portion

  (5,276)  (4,803)

Current portion as of March 31, 2022

 $896 

Current portion as of March 31, 2023

 $983 

 

As of March 31, 2022, 2023, the Company’s operating leases have a weighted-average remaining lease term of 6.215.3 years and a weighted-average discount rate of 4.14%4.15%. The maturities of the operating lease liabilities are as follows:

 

Fiscal year ending September 30,

    

2022 (remaining six months)

 $578 

2023

 1,090 

2023 (remaining six months)

 $598 

2024

 1,087  1,208 

2025

 1,058  1,184 

2026

 1,071  1,198 

2027

 1,220 

Thereafter

  2,139   1,047 

Total undiscounted operating lease payments

 7,023  6,455 

Less imputed interest

  (851)  (669)

Present value of operating lease liabilities

 $6,172  $5,786 

 

For the three months ended March 31, 2022 2023 and 2021,2022, total lease expense under operating leases was approximately $246$245 and $245,$246, respectively. For the six months ended March 31, 2022 2023 and 2021,2022, total lease expense under operating leases was approximately $503 and $491, respectively. The Company recorded $4 in short-term lease expense during the three and $490, respectively.six months ended March 31, 2023. The Company did not have any short-term lease expense during the three and six months ended March 31, 2022 and 2021.

16

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

2022.

 

 

13. INCOME TAXES

 

For the six months ended March 31, 2023, the Company recorded discrete income tax expense of $8 related to a prior year foreign income tax expense true-up. For the six months ended March 31, 2023, the Company did not record an income tax benefit for the tax loss, as the benefits are not expected to be realized during the current fiscal year through ordinary income generated during the third and fourth quarters or in a future year through recognition of a deferred tax asset. For the six months ended March 31, 2022, the Company recorded an income tax benefit of $336 reflecting an effective tax rate of 28.6%. For

The Company expects to utilize its deferred tax asset in the six months ended March 31, 2021, the Company recorded incomefuture, except for those related to federal R&D tax expense of $278 reflecting an effectivecredit carryforwards and net operating loss carryforwards, R&D credits, and foreign tax rate of 26.4%. The Companycredits related to Genasys Spain and Genasys Canada, and continues to maintain a partial valuation allowance against its deferred tax assets as the Company believes that the negative evidence that it will be able to recover these net deferred tax assets outweighs the positive evidence.allowance.

 

ASC 740, Accounting for Uncertainty in Income Taxes, requires the Company to recognize in its consolidated financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. If interest or penalties are assessed, the Company would recognize these charges as income tax expense. The Company has not recorded any income tax expense or benefit for uncertain tax positions.

 

15

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

14. COMMITMENTS AND CONTINGENCIES

 

Litigation

 

The Company may at times be involved in litigation in the ordinary course of business. The Company will, from time to time, when appropriate in the Company’s estimation, record adequate reserves in the Company’s consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

 

Bonus plan

 

The Company has a bonus plan for employees, in accordance with their terms of employment, whereby they can earn a percentage of their salary based on meeting targeted objectives for orders received, revenue, operating income and operating cash flow. In the six months ended March 31, 2022, 2023, the Company recorded $845$589 of bonus expense. In the six months ended March 31, 2021, 2022, the Company recorded $898$845 of bonus expense.

 

Amika Mobile asset purchase

 

In connection with the Amika Mobile asset purchase, the Company recorded a holdback liability related to potential future adjustments to assets and liabilities, misrepresentations, and indemnifications against third-partythird-party claims. Adjustments of up to CAD$1,000 ( (USD$USD$799739) will be deducted from the asset purchase holdback liability for up to three years from the closing date. The liability is recorded at fair value in the condensed consolidated balance sheet.

 

The Company also agreed to issue 191,267 shares of the Company’s common stock to the former owners of Amika Mobile on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98 per share, resulting in the addition of $3,431 to additional paid-in-capital. During the year ended September 30, 2021, the Company accelerated the issuance of 365,109 of such shares of common stock to a former owner of the Amika Mobile assets. During the year ended September 30, 2022, the Company issued 69,564 shares to the former owners of the Amika Mobile assets. During the six months ended March 31, 2022, 2023, the Company issued 69,564 shares to the former owners of the Amika Mobile assets. There are 139,12869,564 remaining shares of the Company’s common stock subject to issuance under this obligation.

 

 

15. SHARE-BASED COMPENSATION

 

Stock option plans

 

As of March 31, 2022, the Company had two equity incentive plans. The 2005 Equity Incentive Plan ((“2005 Equity Plan”) was terminated with respect to new grants in March 2015 but remains in effect for grants issued prior to that time. The Amended and Restated 2015 Equity Incentive Plan ((“2015 Equity Plan”) was adopted by the Company’s Board of Directors on December 6, 2016, and approved by the Company’s stockholders on March 14, 2017. The 2015 Equity Plan was amended by the Company’s Board of Directors on December 8, 2020, to increase the number of shares authorized for issuance from 5,000,000 to 10,000,000. On March 16, 2021, the Company’s stockholders approved athe plan amendment. The 2015 Equity Plan authorizes the issuance of stock options, restricted stock, stock appreciation rights, restricted stock units (“RSUs”) and performance awards, to an aggregate of 10,000,000 new shares of common stock to employees, directors, advisors or consultants. As of March 31, 2022, 2023, there were options and restricted stock units outstanding covering 60,0001,000 and 3,300,3114,579,035 shares of common stock under the 2005 Equity Plan and the 2015 Equity Plan, respectively, and 4,525,3152,861,077 shares of common stock available for grant, for a total of 7,885,6267,441,112 shares of common stock authorized and unissued under the two equity plans.

 

17

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Share-based compensation

 

The Company’s employee stock options have various restrictions that reduce option value, including vesting provisions and restrictions on transfer and hedging, among others, and are often exercised prior to their contractual maturity.

 

Share-based compensation is accounted for in accordance with ASC Topic 718: Compensation - Stock Compensation. Total compensation expense for all share-based awards is based on the estimated fair market value of the equity instrument issued on the grant date. For share-based awards that vest based solely on a service condition, compensation expense is recognized on a straight-line basis over the total requisite service period for the entire award. For share-based awards that vest based on a market condition, compensation expense is recognized on a straight-line basis over the requisite service period of each separately vesting tranche. For share-based awards that vest based on a performance condition, compensation expense is recognized for the number of awards that are expected to vest based on the probable outcome of the performance condition. Compensation cost for these awards will be adjusted to reflect the number of awards that ultimately vest.

16

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

There were 1,806,500 stock options granted during the six months ended March 31, 2023, of which 225,000 vest based on a market condition. There were 302,000 stock options granted during the six months ended March 31, 2022. There were 245,000 stock2022, none of which vest based on a market condition.

Stock options granted duringthat do not contain market-based vesting conditions are valued using the six months ended March 31, 2021. Black-Scholes option pricing model. The weighted average estimated fair value of employee stock options granted, that vest without a market condition, during the six months ended March 31, 2022 2023 and 2022, was calculated using the Black-Scholes option-pricing model with the following weighted average assumptions (annualized percentages):

 

 

Six months ended

  

Six months ended

 
 

March 31,

  

March 31

 
 

2022

  

2021

  

2023

  

2022

 

Volatility

 48.1%  48.5%  52.1%  48.1% 

Risk-free interest rate

 1.5%  0.6%  4.0%  1.5% 

Dividend yield

 0.0%  0.0%  0.0%  0.0% 

Expected term in years

 6.8  6.8  5.8  6.8 

 

Expected volatility is based on the historical volatility of the Company’s common stock over the period commensurate with the expected term of the options. The risk-free interest rate is based on rates published by the Federal Reserve Board. The contractual term of the options was seven years. The expected term is based on observed and expected time to post-vesting exercise. The expected forfeiture rate is based on past experience and employee retention data. Forfeitures are estimated at the time of the grant and revised in subsequent periods if actual forfeitures differ from those estimates. Such revision adjustments to expense will be recorded as a cumulative adjustment in the period in which the estimate is changed. The Company has not paid a dividend in fiscal 20222023 and did not pay a dividend in fiscal 2021.2022.

For stock options that contain market-based vesting conditions, the fair value of these options was determined using a Monte Carlo valuation approach and calculated by an independent valuation specialist.

 

As of March 31, 2022, 2023, there was approximately $1,114$1,976 of total unrecognized compensation costs related to outstanding employee stock options. This amount is expected to be recognized over a weighted average period of 1.62.4 years. To the extent the forfeiture rate is different from what the Company anticipated, stock-based compensation related to these awards will be different from the Company’s expectations.

 

Performance-based stock options

 

On October 4, 2019, the Company awarded a performance-based stock option (PVO) to purchase 800,000 shares of the Company’s common stock to a key executive, with a contractual term of seven years. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2022 and 2023 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets. During the year ended September 30, 2022, the Company modified the performance criteria for these PVOs to exclude certain strategic growth initiatives that were not planned at the time of grant. The Company recorded $209 in stock-based compensation expense related to these options in the year ended September 30, 2022. The Company did not record compensation expense related to the 2023 performance-based stock options during the six months ended March 31, 2023.

On October 8, 2022, the Company awarded additional performance-based stock options to purchase 800,000 shares of the Company’s common stock to the same key executive, with a contractual term of seven years. Vesting is based upon the achievement of certain performance criteria for each of fiscal 2025 and 2026 including a minimum free cash flow margin and net revenue targets. Additionally, vesting is subject to the executive being employed by the Company at the time the Company achieves such financial targets. The Company has did not recorded stock-based record compensation expense related to these options.options for the six months ended March 31, 2023.

On August 10, 2022, the Company granted PVOs to purchase up to 750,000 shares of the Company’s common stock to a key member of management, with a contractual term of seven years. During the three months ended March 31, 2023, these options were forfeited due to a voluntary termination of employment. The Company did not record compensation expense related to these options for the six months ended March 31, 2022.

On March 20, 2023, the Company granted PVOs to purchase up to 450,000 shares of the Company’s stock to a key member of management with a contractual term of seven years. Vesting is based upon the achievement of certain performance criteria for each of the first three twelve-month periods following the employee’s start date, including targets related to growth in the institutional ownership of the Company’s common stock and growth in the trading volume of the Company’s common stock during such periods. Additionally, vesting is subject to the employee being employed by the Company on each of the first three anniversaries of the employee’s start date. 225,000 of these options contain a market-based vesting condition and accounting principles do not require the market condition to be achieved in order for compensation expense to be recognized. The Company recorded $0.4 of compensation expense related to these options during the three and six months ended March 31, 2023.

 

The Company did not grant any PVO’s during the six months ended March 31, 2022 2022.

17

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and 2021.

share amounts)
(Unaudited)

 

Restricted stock units

 

On March 10,In fiscal 2020,each non-employee member of the Board of Directors received a grant of 30,000 RSUs that vested on the first anniversary of the grant date. These were issued at a market value of $425, which were expensed on a straight-line basis through the March 10, 2021 vest date. Also, in fiscal 2020, 81,270 RSUs were granted to employees that will vestvested over three years on the anniversary date of the grant. These were issued at a market value of $258 whichand have and will bebeen expensed on a straight-line basis over the three-yearthree-year life of the grants.

 

On March 16,During fiscal 2021,each non-employee member of the Board of Directors received a grant of 27,883 RSUs that will vest on the first anniversary of the grant date. These were issued at a market value of $1,100, which have and will be expensed on a straight-line basis through the March 16, 2022 vest date. Also, during fiscal 2021, 145,950 RSUs were granted to employees that will vest over three years on the anniversary date of the grant. These were issued at a market value of $989, which have and will be expensed on a straight-line basis over the three-yearthree-year life of the grants.

On June 7, 2021, 5,000 RSUs with immediate vesting were granted to an employee at a market value of $25. These were expensed during the quarter ended June 30, 2021. On September 1, 2021, two new membersMarch 15, 2022, each non-employee member of the Board of Directors received a grant of 17,50030,000 RSUs which will vestthat vested on March 16, 2022. the first anniversary of the grant date. These were issued at a market value of $184,$407, and expensed on a straight-line basis through the March 15, 2023, vest date. On November 1, 2021, 10,000 RSUs were granted to a non-employee advisor that vested on the first anniversary of the grant date. These were issued at a market value of $51, which were expensed on a straight-line basis though the November 1, 2022, vest date. On November 1, 2022, 10,000 RSUs were granted to a non-employee advisor that vest on the first anniversary of the grant date. These were issued at a market value of $29, which have and will be expensed on a straight-line basis throughthough the March 16, 2022 November 1, 2023, vest date.

 

On March 15, 2022, 14, 2023, each non-employee member of the Board of Directors received a grant of 30,000 RSUs that will vest on the first anniversary of the grant date. These RSUs were issuedgranted at a market value of $407, which$417 and have and will be expensed on a straight-line basis through the March 15, 2023 14, 2024, vest date. On November 1, 2021, 10,000February 14, 2023, 145,600 RSUs were granted to a non-employee advisoremployees that will vest over three years on the firstanniversary date of the grant date.grant. These RSUs were issued at a market value of $51, which have and will be expensed on a straight-line basis though the November 1, 2022 vest date. Also, during the six months ended March 31, 2022, there were 100,800 RSUs granted to employees that will vest over three years on the anniversary of the grant date. These were issued at a market value of $348,$582, which have and will be expensed on a straight-line basis over the three-yearthree-year life of the grants. On March 20, 2023, 20,000 RSUs were granted to an employee with immediate vesting. These were issued at a market value of $66 and were expensed immediately.

 

Compensation expense for RSUs was $350 and $548 for the three and six months ended March 31, 2023, respectively. Compensation expense for RSUs was $586 and $1,023 for the three months and six months ended March 31, 2022, respectively. Compensation expense for RSUs was $249 and $387 for the three and six months ended March 31, 2021, respectively. As of March 31, 2022, 2023, there was approximately $1,181$1,473 of total unrecognized compensation costs related to outstanding RSUs. This amount is expected to be recognized over a weighted average period of 1.681.8 years.

 

18

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

A summary of the Company’s RSUs as of March 31, 2022 2023, is presented below:

 

 

Number of

Shares

  

Weighted

Average Grant

Date Fair Value

  

Number of

Shares

  

Weighted

Average Grant

Date Fair Value

 

Outstanding September 30, 2021

 399,469  $6.27 

Outstanding September 30, 2022

 342,841  $4.11 

Granted

 260,800  $3.09  295,600  $3.63 

Released

 (262,342) $6.46  (245,428) $3.68 

Forfeited/cancelled

  (15,000) $5.05   -  $- 

Outstanding March 31, 2022

  382,927  $4.03 

Outstanding March 31, 2023

  393,013  $4.01 

 

Stock option summary information

 

A summary of the activity in options to purchase the capital stock of the Company as of March 31, 2022 2023, is presented below:

 

 

Number of

Shares

  

Weighted

Average

Exercise Price

  

Number of

Shares

  

Weighted

Average

Exercise Price

 

Outstanding September 30, 2021

 2,745,384  $3.02 

Outstanding September 30, 2022

 3,940,899  $3.31 

Granted

 302,000  $4.87  1,806,500  $2.93 

Forfeited/expired

 0  $0  (1,476,612) $3.99 

Exercised

  (70,000) $2.43   (83,765) $

1.60

 

Outstanding March 31, 2022

  2,977,384  $3.23 

Exerciseable March 31, 2022

  1,562,503  $2.42 

Outstanding March 31, 2023

  4,187,022  $2.94 

Exerciseable March 31, 2023

  1,698,888  $2.59 

18

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

Options outstanding are exercisable at prices ranging from $1.31 to $8.03 per share and expire over the period from 20222023 to 20282030 with an average life of 3.724.39 years. The aggregate intrinsic value of options outstanding and exercisable as of March 31, 2022 2023, was $1,067$1,381 and $1,067,$1,095, respectively. The aggregate intrinsic value represents the difference between the Company’s closing stock price on the last day of trading for the quarter, which was $2.75$2.95 per share, and the exercise price multiplied by the number of applicable options. The total intrinsic value of stock options exercised during the six months ended March 31, 2022 2023 was $86$147 and proceeds from these exercises was $170.$86. The total intrinsic value of stock options exercised during the six months ended March 31, 2021 2022 was $455$86 and proceeds from these exercises was $170.

 

The following table summarized information about stock options outstanding as of March 31, 2022:2023:

 

      

Weighted Average

 

Weighted Average

     

Weighted Average

        

Weighted Average

 

Weighted Average

     

Weighted Average

 

Range of

Range of

 

Number

 

Remaining

 

Exercise

 

Number

 

Exercise

 

Range of

 

Number

 

Remaining

 

Exercise

 

Number

 

Exercise

 

Exercise Prices

Exercise Prices

 

Outstanding

 

Contractual Term

 

Price

 

Exercisable

 

Price

 

Exercise Prices

 

Outstanding

  

Contractual Term

  

Price

  

Exercisable

  

Price

 

$1.31

-$1.86 319,157  1.51  $1.64  319,157  $1.64 -$1.99 1,097,657  0.98  $1.95  1,097,657  $1.95 

$1.99

-$1.99 937,500  1.94  $1.99  937,500  $1.99 

$3.39

-$3.39 800,000  4.51  $3.39  0  $0 
$2.69-$2.69 1,100,000  6.52  $2.69  -  $- 
$3.12-$3.39 1,151,138  5.17  $3.33  187,138  $3.39 

$3.40

-$4.99 635,727  5.53  $4.10  237,745  $3.60 -$8.03  838,227   5.01  $4.04   414,093  $3.93 

$5.05

-$8.03  285,000   5.80  $6.66   80,780  $6.94 
   2,977,384   3.72  $3.23   1,575,182  $2.42     4,187,022   4.39  $2.94   1,698,888  $2.59 

 

The Company recorded $151$163 and $79$151 of stock option compensation expense for employees, directors and consultants for the three months ended March 31, 2022, 2023 and 2021,2022, respectively. The Company recorded $272$385 and $123$272 of stock option compensation expense for employees, directors and consultants for the six months ended March 31, 2022, 2023 and 2021,2022, respectively.

 

19

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Share-based compensation

 

The Company recorded share-based compensation expense and classified it in the condensed consolidated statements of operations as follows:

 

 

Three Months Ended

 

Six Months Ended

  

Three Months Ended

 

Six Months Ended

 
 

March 31,

 

March 31,

  

March 31,

 

March 31,

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

  

2023

  

2022

 

Cost of revenues

 28  $9  43  15  $33  $28  $61  $43 

Selling, general and administrative

 686  309  1,217  479  447  686  820  1,217 

Research and development

  23   10   35   16   33   23   52   35 
 $737  $328  $1,295  $510  $513  $737  $933  $1,295 

19

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

 

16. STOCKHOLDERS EQUITY

 

Summary

 

The following table summarizes changes in the components of stockholders’ equity during the six months ended March 31, 2023, and the six months ended March 31, 2022 and the six months ended March 31, 2021 (amounts(amounts in thousands, except par value and share amounts):

                 

Accumulated

                     

Accumulated

    
 

Common Stock

 

Additional

     

Other

 

Total

  

Common Stock

  

Additional

      

Other

  

Total

 
 

Shares

  

Par Value Amount

  

Paid-in Capital

  

Accumulated Deficit

  

Comprehensive Loss

  

Stockholders' Equity

  

Shares

  

Par Value

Amount

  

Paid-in

Capital

  

Accumulated

Deficit

  

Comprehensive

Loss

  

Stockholders'

Equity

 

Balance as of September 30, 2021

 36,403,833  $364  $107,110  $(41,154) $2  $65,958 

Balance as of September 30, 2022

 36,611,240  $366  $108,551  $(57,366) $(792) $50,393 

Share-based compensation expense

 -  0  558  0  0  558  -  -  420  -  -  420 

Issuance of common stock upon exercise of stock options, net

 15,000  0  46  0  0  46  20,000  -  32  -  -  32 

Stock buyback

 (116,868) (1) (441) 0  0  (441)

Issuance of common stock upon vesting of restricted stock units

 12,667  -  -  -  -  - 

Release of obligation to issue commons stock

 69,564  0  0  0  0  0  69,564  1  -  -   - 

Accumulated other comprehensive loss

 -  0  0  0  (85) (85) -  -  -  -  266  266 

Net loss

  -   0   0   (1,305)  0   (1,305)  -   -   -   (3,507)     (3,507)

Balance as of December 31, 2021

  36,371,529  $363  $107,273  $(42,459) $(83) $64,731 

Balance as of December 31, 2022

  36,713,471  $367  $109,003  $(60,873) $(526) $47,604 
              

Share-based compensation expense

 -  0  737  0  0  737  -  -  513  -  -  513 

Issuance of common stock upon exercise of stock options, net

 55,000  1  124  0  0  124  33,765  1  54  -  -  54 

Issuance of common stock upon cashless exercise of stock options, net

 15,914  -  -  -  -  - 

Issuance of common stock upon vesting of restricted stock units

 262,342  2  0  0  0  0  232,761  2  (2) -  -  (2)

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

 (18,344) 0  (70) 0  0  (70) (11,616) -  (45) -  -  (45)

Stock buyback

 (142,442) (1) (557) 0  0  (557)

Accumulated other comprehensive loss

 -  0  0  0  (1) (1) -  -  -  -  81  81 

Net loss

  -   0   0   (492)  0   (492)  -   -   -   (3,403)  -   (3,403)

Balance as of March 31, 2022

  36,528,085  $365  $107,507  $(42,951) $(84) $64,472 

Balance as of March 31, 2023

  36,984,295  $370  $109,523  $(64,276) $(445) $44,802 

 

20

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

                 

Accumulated

     

Common Stock

  

Additional

      

Other

  

Total

 
 

Common Stock

 

Additional

     

Other

 

Total

  

Shares

  

Par Value

Amount

  

Paid-in

Capital

  

Accumulated

Deficit

  

Comprehensive

Loss

  

Stockholders'

Equity

 
 

Shares

  

Par Value Amount

  

Paid-in Capital

  

Accumulated Deficit

  

Comprehensive Loss

  

Stockholders' Equity

 

Balance as of September 30, 2020

 33,561,544  $336  $91,248  $(41,858) $(250) $49,140 

Balance as of September 30, 2021

 36,403,833  $364  $107,110  $(41,154) $2  $65,958 

Share-based compensation expense

 -  0  182  0  0  182  -  -  558  -  -  558 

Issuance of common stock upon exercise of stock options, net

 25,899  0  54  0  0  54  15,000  -  46  -  -  46 

Obligation to issue common stock

 -  0  3,431  0  0  3,431 

Accumulated other comprehensive income

 -  0  0  0  469  469 

Stock buyback

 (116,868) (1) (441) -  -  (441)

Release of obligation to issue commons stock

 69,564  -  -  -  -  - 

Accumulated other comprehensive loss

 -  -  -  -  (85) (85)

Net loss

  -   0   0   (619)  0   (619)  -   -   -   (1,305)  -   (1,305)

Balance as of December 31, 2020

  33,587,443  $336  $94,915  $(42,477) $219  $52,657 

Balance as of December 31, 2021

  36,371,529   363  $107,273  $(42,459) $(83) $64,731 
              

Share-based compensation expense

 -  $0  $328  $0  $0  $328  -  -  737  -  -  737 

Issuance of common stock upon exercise of stock options, net

 60,563  1  116  0  0  116  55,000  1  124  -  -  124 

Issuance of common stock upon vesting of restricted stock units

 223,633  2  0  0  0  0  262,342  2  -  -  -  - 

Shares retained for payment of taxes in connection with net share settlement of restricted stock units

 (22,073) 0  (141) 0  0  (141) (18,344) -  (70) -  -  (70)

Stock buyback

 (142,442) (1) (557) -  -  (557)

Accumulated other comprehensive loss

 -  0  0  0  (78) (78) -  -  -  -  (1) (1)

Net income

  -   0   0   262   0   262 

Balance at March 31, 2021

  33,849,566  $339  $95,218  $(42,215) $141  $53,144 

Net loss

  -   -   -   (492)  -   (492)

Balance as of March 31, 2022

  36,528,085   365  $107,507  $(42,951) $(84) $64,472 

 

Common stock activity

 

During the six months ended March 31, 2023, the Company issued 69,679 shares of common stock and received gross proceeds of $86 in connection with the exercise of stock options, and the Company issued 233,812 shares of common stock in connection with the vesting of RSUs. During the six months ended March 31, 2022 the Company issued 70,000 shares of common stock and received gross proceeds of $170 in connection with the exercise of stock options, and the Company issued 243,998 shares of common stock in connection with the vesting of RSUs. During

21

Genasys Inc.
Notes to the six months ended March 31, 2021, the Company issued 86,462 shares of common stockCondensed Consolidated Financial Statements
(in thousands, except per share and received gross proceeds of $170 in connection with the exercise of stock options and the Company issued 201,560 shares of commons stock in connection with the vesting of RSUs.

share amounts)
(Unaudited)

 

In connection with the Amika Mobile asset purchase, the Company agreed to issue 191,267 shares of the Company’s common stock to the former owners of Amika Mobile on each of the first, second and third anniversaries of the closing date. The total number of shares of common stock the Company is obligated to issue is 573,801. The fair value of the Company’s common stock on the closing date was $5.98 per share, resulting in the addition of $3,431 to additional paid-in-capital. During the year ended September 30, 2021, the Company accelerated the issuance of 365,109 of such shares of common stock to a former owner of the Amika Mobile assets. During the year ended September 30, 2022, the Company issued 69,564 shares to the former owners of the Amika Mobile assets. During the six months ended March 31, 2022, 2023, the Company issued 69,564 shares to the former owners of the Amika Mobile assets. There are 139,12869,564 remaining shares of the Company’s common stock subject to issuance under this obligation.

 

Share buyback program

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019, and expiring on December 31, 2020, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the Board of Directors extended the buyback program until December 31, 2022. The previousIn December 2022, the Board of Directors extended the Company’s share buyback program expired on through December 31, 2018.2024.

 

There were no shares repurchased during the six months ended March 31, 2023. During the six months ended March 31, 2022 259,310 shares were repurchased for $998. There were 0All repurchased shares repurchased during the six months ended have been retired as of March 31, 2021. As of March 31, 2022, all repurchased shares were retired.2023, and $3 million was available for share repurchase under the program.

 

Dividends

 

There were 0no dividends declared in the six months ended March 31, 2022 2023 and 2021.

21

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

2022.

 

 

17. NET (LOSS) INCOMELOSS PER SHARE

 

The following table sets forth the computation of basic and diluted net (loss) incomeloss per share:

 

 

Three months ended

 

Six months ended

  

March 31,

 

March 31,

 
 

March 31,

  

March 31,

  

2023

 

2022

 

2023

 

2022

 

Net loss

 $(3,403) $(492) $(6,910

)

 $(1,797

)

 

2022

  

2021

  

2022

  

2021

  

Net (loss) income

 $(492) $262  $(1,797) $(357)
 

Basic (loss) income per share

 $(0.01) $0.01  $(0.05) $(0.01)

Diluted (loss) income per share

 $(0.01) $0.01  $(0.05) $(0.01)

Basic and diluted income per share

 $(0.09) $(0.01) $(0.19

)

 $(0.05

)

  

Weighted average shares outstanding - basic

 36,353,321  33,683,240  36,405,321  33,629,479  36,817,026  36,535,321  36,755,920  36,405,321 

Assumed exercise of dilutive options

  0   1,096,026   0   0   -   -   -   - 

Weighted average shares outstanding - diluted

  36,353,321   34,779,266   36,405,321   33,629,479   36,817,026   36,535,321   36,755,920   36,405,321 
  

Potentially diluted securities outstanding at period end excluded from diluted computation as the inclusion would have been antidilutive:

  

Options

 2,977,384  830,000  2,977,384  2,723,718  4,187,022  2,977,384  4,187,022  2,977,384 

RSU

 382,927  0  382,927  325,669  393,013  382,927  393,013  382,927 

Obligation to issue common stock

  139,128   0   139,128   0   69,564   139,128   69,564   139,128 

Total

  3,499,439   830,000   3,499,439   3,049,387   4,649,599   3,499,439   4,649,599   3,499,439 

22

Genasys Inc.
Notes to the Condensed Consolidated Financial Statements
(in thousands, except per share and share amounts)
(Unaudited)

 

 

18. SEGMENT INFORMATION

 

The Company is engaged in the design, development and commercialization of directed and multidirectional sound technologies, voice broadcast products, and location-based mass messaging software for emergency warning and evacuation management. The Company operates in 2two business segments: Hardware and Software and its principal markets are North and South America, Europe, the Middle East, and Asia. As reviewed by the Company’s chief operating decision maker, the Company evaluates the performance of each segment based on sales and operating income. Cash and cash equivalents, marketable securities, accounts receivable, inventory, property and equipment, deferred tax assets, goodwill and intangible assets are primary assets identified by segment. The accounting policies for segment reporting are the same for the Company as a whole.

 

22

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

The following table presents the Company’s segment disclosures:

 

 

Three months ended

 

Six months ended

 
 

March 31,

 

March 31,

  

Three months ended

 

Six months ended

 
 

2022

  

2021

  

2022

  

2021

  

March 31,

 

March 31,

 
          

2023

  

2022

  

2023

  

2022

 

Revenue from external customers

          

Hardware

 $12,495  $10,625  $22,622  $18,012  $10,360  $12,495  $19,945  $22,622 

Software

  673   676   1,223   1,317   853   673   1,755   1,223 
 $13,168  $11,301  $23,845  $19,329  $11,213  $13,168  $21,700  $23,845 
          

Intersegment revenues

          

Hardware

 $0  $0  0  $0  $-  $-  $-  $- 

Software

  820   254   1,494   606   1,386   820   2,582   1,494 
 $820  $254  $1,494  $606  $1,386  $820  $2,582  $1,494 
          

Segment operating income (loss)

         

Segment operating loss

 

Hardware

 $2,537  $1,796  $3,709  $2,304  $387  $2,537  $359  $3,709 

Software

  (3,064)  (1,243)  (5,845)  (2,444)  (3,797)  (3,064)  (7,257)  (5,845)
 $(527) $553  $(2,136) $(140) $(3,410) $(527) $(6,898) $(2,136)
          

Other expenses:

          

Depreciation and amortization expense

          

Hardware

 $96  $93  $190  $183  $100  $96  $199  $190 

Software

  547   177   1,092   369   539   547   1,083   1,092 
 $643  $270  $1,282  $552  $639  $643  $1,282  $1,282 
          

Income tax expense (benefit)

          

Hardware

 $726  $412  $1,066  $531  $8  $726  $8  $1,066 

Software

  (771)  (129)  (1,402)  (253)  -   (771)  -   (1,402)
 $(45) $283  $(336) $278  $8  $(45) $8  $(336)

 

  

March 31,

  

September 30,

 
  

2022

  

2021

 

Long-lived assets

        

Hardware

 $1,706  $1,748 

Software

  35,585   36,645 
  $37,291  $38,393 
         

Total assets

        

Hardware

 $47,237  $50,364 

Software

  37,821   39,764 
  $85,058  $90,128 

  

March 31,

  

September 30,

 
  

2023

  2022 

Long-lived assets

        

Hardware

 $1,564  $1,677 

Software

  9,623   10,585 
  $11,187  $12,262 
         

Total assets

        

Hardware

 $38,848  $47,237 

Software

  22,854   24,617 
  $61,702  $71,854 

 

 

19. MAJOR CUSTOMERS, SUPPLIERS AND RELATED INFORMATION

 

For the three months ended March 31, 2023, revenues from two customers accounted for 54% and 12% of total revenues with no other single customer accounting for more than 10% of revenues. For the six months ended March 31, 2023, revenues from one customer accounted for 57% of total revenues with no other single customer accounting for more than 10% of revenues. As of March 31, 2023, accounts receivable from two customers accounted for 26% and 23% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

For the three months ended March 31, 2022 revenues from 2two customers accounted for 63% and 13% of total revenues with no other single customer accounting for more than 10% of revenues. For the six months ended March 31, 2022, revenues from one customer accounted for 65% of total revenues with no other single customer accounting for more than 10% of revenues. As of March 31, 2022, accounts receivable from two customers accounted for 56% and 17% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

23

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

For the three months ended March 31, 2021, revenues from one customer accounted for 47% of total revenues with no other single customer accounting for more than 10% of revenues. For the six months ended March 31, 2021, revenues from 1 customer accounted for 49% of total revenues with no other single customer accounting for more than 10% of revenues. As of March 31, 2021, accounts receivable from 2 customers accounted for 33% and 25% of total accounts receivable, with no other single customer accounting for more than 10% of the accounts receivable balance.

 

Revenue from customers in the United States was $9,531$8,411 and $8,086$9,531 for the three months ended March 31, 2022 2023 and 2021,2022, respectively. Revenue from customers in the United States was $18,769$17,349 and $13,837$18,769 for the six months ended March 31, 2023 and 2022, and 2021,respectively. The following table summarizes revenues by geographic region. Revenues are attributed to countries based on customer’scustomers’ delivery location. The following table summarizes revenues by geographic region.

 

 

Three months ended

 

Six months ended

 
 

March 31,

 

March 31,

  

Three months ended March 31,

 

Six months ended March 31,

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

  

2023

  

2022

 

Americas

 $10,095  $8,598  $19,531  $14,406  $10,019  $10,095  $19,182  $19,531 

Asia Pacific

 2,147  2,213  2,455  3,223  545  2,147  1,304  2,455 

Europe, Middle East and Africa

  926   490   1,859   1,700   649   926   1,214   1,859 

Total Revenues

 $13,168  $11,301  $23,845  $19,329  $11,213  $13,168  $21,700  $23,845 

 

The following table summarizes long livedlong-lived assets by geographic region.

 

 

March 31,

 

September 30,

  

March 31,

 

September 30,

 
 

2022

  

2021

  

2023

  

2022

 

United States

 $26,078  $26,880  $10,724  $11,800 

Americas (excluding the United States)

 8,330  8,395  12  16 

Europe, Middle East and Africa

  2,883   3,118   451   446 

Total long lived assets

 $37,291  $38,393  $11,187  $12,262 

 

24

 

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Item 2.

Item2. Managements Discussion and Analysis of Financial Condition and Results of Operations

 

The discussion and analysis set forth below should be read in conjunction with the accompanying unaudited condensed consolidated financial statements and the related notes included under Item 1 of this Quarterly Report on Form 10-Q, together with Management’s Discussion and Analysis of Financial Condition and Results of Operations included in our Annual Report on Form 10-K for the year ended September 30, 2021.2022.

 

Forward Looking Statements

 

This report contains certain statements of a forward-looking nature relating to future events or future performance. Words such as expects, anticipates, intends, plans, believes, seeks, estimates and similar expressions or variations of such words are intended to identify forward-looking statements but are not the only means of identifying forward-looking statements. Prospective investors are cautioned that such statements are only predictions and actual events or results may differ materially. In evaluating such statements, prospective investors should specifically consider various factors identified in this report and any matters set forth under Part I, Item 1A (Risk Factors) of our Annual Report on Form 10-K, which could cause actual results to differ materially from those indicated by such forward-looking statements.

 

For purposes of this Quarterly Report, the terms we, us, our Genasys and the Company refer to Genasys Inc. and its consolidated subsidiaries.

 

Overview

 

Genasys is a global provider of critical communications hardwaresoftware solutions and softwarehardware systems designed to alert, inform, and inform to help keep people safe. Ourprotect communities and organizations. The Genasys Protect™ unified platform receivescollects information on developing and active emergency situations from a wide variety of sensors and Internet-of-Things (IoT) inputs and empowers governments, businesses, and organizations to collectdeliver real-time, information on developinggeo-targeted notifications and active emergency situations. Genasys uses this information to create and disseminate alerts, warnings, notifications, and instructions through multiple channelspeople in harm’s way before, during, and after public safety and enterprise threats, critical events, and other crisis situations.threats.

 

Our multi-channel approachThe Genasys Protect unified platform includes:

 

Software

GEM

Genasys Emergency Management (“GEM”) is Genasys’ software-as-a-service (“SaaS”) product platform that includes GEM Public Safety, GEM Enterprise, Zonehaven and NEWS.

Genasys Emergency Management (GEM) is Genasys’ software-based product platform. The GEM product line consists of GEM Software, IMNS, and Zonehaven.

 

GEM SoftwarePublic Safety is an interactive, cloud-based SaaS solution that sendsenables State, Local and Education (“SLED”) customers to send critical information to at-risk individuals or groups critical information when an emergency occurs. GEM Software acts as both a communications input and output, receiving information from state-of-the-art sensors and emergency services, and quickly relaying notifications, alerts, and instructions to at-risk populations and first responders. GEM Software operatorscustomers can create and send critical, verified, and secure notifications and messages using emails, voice calls, text messages, panic buttons, desktop alerts, television, social media, and more. Additionally, Genasys is a certified provider of Integrated Public Alert and Warning System (“IPAWS”) notifications.

 

Integrated Mass Notification System (IMNS)GEM Enterprise is Genasys’ comprehensive emergency response solution, unitingempowers businesses and organizations to send critical communications to at-risk employees, contractors, visitors, or groups based on geographic location or team status. Operated and controlled via a single dashboard that includes two-way polling, duress buttons, field check-ins, and recipient locations, GEM SoftwareEnterprise integrates with data sources, including active directories, human resources, visitor management, and Genasys speaker system hardware in a multichannel solution. IMNS gives operators the abilitybuilding control systems to communicate criticalfind and deliver safety alerts and notifications across platforms using a commandto employees, staff, contractors, temporary workers, and control interface that can be accessed from an emergency operations center, authorized computer, or smart phone. Notifications can be sent using text messages, emails, IPAWS, desktop alerts, television, voice calls, social media, and Genasys speaker systems. By providing several digital, software-based notifications and audible voice alerts through speakers, IMNS creates layered redundancy to enable the maximum number of people receive critical communications.visitors.

 

Zonehavenis a multipronged SaaS application that serves both first responders and the communitiesjurisdictions they protect. ZonehavenEmergency services agencies can function as a standalone applicationprepare for natural or as a GEM Software integration. When an incident occurs,man-made disasters by developing evacuation plans that map routes, shelters, traffic control locations, and road closures using Zonehaven's extensive public safety resources and mapped zones. This information is easily shared with the public and reduces the time it is immediately tracked by the Zonehaven platform, which maps the incident, simulates the speedtakes to execute emergency evacuations and direction of the incident, and determines which zones (geographic areas) are at risk and need to be evacuated. As an incident develops, Zonehaven’s real-time updates provide emergency organizations and at-risk populations up-to-date information to stay safe.conduct orderly repopulations.

 

National Emergency Warning System (NEWS) provides multichannel public safety notifications and instructions to designated areas, groups, or agencies when a crisis occurs. The NEWS platform is cloud-based, geo-redundant, and end-to-end encrypted. NEWS is a SaaS product that requires mobile telecom services for installation, integration and to deliver Location-based SMS and Cell Broadcast alerts and notifications that can be sent to anyone, anywhere, with no recipient opt-in, registration, or download required. NEWS can locate recipients and deliver messages in near real time, while other SMS alert providers can take up to 15 minutes. NEWS’ data is anonymized to help

NEWS – Genasys' National Emergency Warning System (“NEWS”) provides multichannel public safety notifications and instructions to designated areas, groups, or agencies when a crisis occurs. Genasys partners with mobile telecom networks to deliver NEWS SMS and cell broadcast alerts and notifications that can be sent to anyone, anywhere, with no recipient opt-in, registration, or download required. NEWS can locate recipients and deliver messages in near real time, compared with other SMS alert providers that can take up to 15 minutes. Even with NEWS’ reach and scope, all data is anonymized, ensuring individuals stay safe and informed without sacrificing their privacy.

 

25

 

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)Hardware

 

IMNS Genasys' Integrated Mass Notification System (“IMNS”) product line unites Genasys next generation mass notification speaker systems with GEM command-and-control software. Genasys' advanced mass notification systems feature the industry's highest Speech Transmission Index (“STI”), large directional and omni-directional broadcast coverage areas, and an array of options that enable continued operation when power and telecommunications infrastructure fail.Emergency alerts and information can be sent via individual, grouped or networked IMNS installations, text messages, emails, IPAWS, desktop alerts, television, voice calls, and social media. IMNS' layered redundancy helps to ensure the maximum number of people receive critical communications.

LRAD is the world’s leading Acoustic Hailing Device (AHD) that projects siren tones and audible voice messages with exceptional vocal clarity in a 30° beam from close range to 5,500 meters. LRADs are used throughout the world in multiple applications and circumstances to safely hail and warn, inform and direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives.

 

Our critical communications systemsLRAD is the world’s leading Acoustic Hailing Device (“AHD”). Projecting alert tones and audible voice messages with exceptional vocal clarity in a 30° beam from close range to 5,500 meters. LRADs are being used throughout the world in multiple applications and circumstances to safely hail, warn, inform, direct, prevent misunderstandings, determine intent, establish large safety zones, resolve uncertain situations, and save lives. LRAD voice and alert tone broadcasts cut through background noise and are clearly heard and understood over distance.

LRAD is the de facto standard of the global AHD market with more than 100 countries throughout the worldusing our long-range communication systems in a range of diverse applications that include public safety, emergency warning, mass notification, defense, law enforcement, border and homeland security, critical infrastructure protection, wildlife preservation, and many more.

We continue to develop new communicationcritical communications innovations and believe we have established significant competitive advantages in our principal markets. 

 

Recent Developments

Business developments in the fiscal quarter ended March 31, 2022:2023:

 

 

Genasys NEWS selected by the country of SloveniaAwarded multi-year GEM Enterprise contract to power nationwide public warning systemprovide critical notifications for Aramco

 

 

Expanded Genasys Protect coverage in San Diego County with new Zonehaven evacuation software services and alerting resources into Los Angeles and four additional California Countiescontract

 

 

Awarded $1.97 million public safety mass notification and emergency warning systems contract from the CityHelped to protect millions of Berkeley, California residents during multiple atmospheric river events

 

 

Announced multiple critical communications software contracts in Texasnew and follow-on IMNS orders from the University of California, Berkeley, the City of Laguna Beach, and the Southern Marin Fire Protection District

 

 

AwardedSecured GEM and Zonehaven software services contract in the public safety category from Sourcewellthree contiguous Utah counties

Received LRAD systems order from international mining operations for bird and wildlife preservation

 

Revenues for the Company’s second quarter of fiscal 2022,2023 were $13.2$11.2 million, an increasea $2.0 million decrease from $11.3$13.2 million in the second quarter of fiscal 2021. LRAD ($10.6 million) and IMNS ($1.9 million) revenues2022. Quarterly software revenue of $853 thousand, increased $819 and $1,054, respectively,$180 thousand, year over year, offset by a $6 decrease of $2.1 million in softwarehardware revenue ($673) compared with10.4 million), in the prior yearMarch ended quarter. The timing of budget cycles, government financial issues and military conflict in certain areas of the world, often delay hardware contract awards, resulting in uneven quarterly revenues.revenue. Gross profit increaseddecreased compared to the same quarter in the prior year, primarily as a result of higher sales offset by increased software engineering expenses.component costs for LRADs delivered against legacy contracts and pricing. Operating expenses in the quarter ended March 31, 2022,2023, increased 59.3%8.2% to $7.5$8.3 million, compared with $4.7$7.7 million in the same period in the prior year. The primary driver of the change is personnel hired in conjunction with our stated investment in building our software business. The Company had 201 employees as of March 31, 2023, as compared with 180 in the prior year period. We reported a net loss of $492$3.4 million for the second quarter of fiscal 2022,2023, or a loss of $0.01$(0.09) per share, compared with a net incomeloss of $262,$492 thousand, or $0.01$(0.01) per share, for the same quarter in the prior year.

 

Overall Business Outlook

 

Our products, systems, and solutions continue to gain worldwide awareness and recognition through our sales and marketing efforts, media exposure, product demonstrations, and word of mouth as a result of positive responses and increased acceptance. We believe we have a solid global brand, technology, and product foundation, which we continue to expand to serve new markets and customers for greater business growth. We believe we have strong market opportunities for our product offerings throughout the world in the defense, public safety, emergency warning, mass notification, critical infrastructure protection,event management, and law enforcement sectors as a result of increasing threats topublic safety, enterprise, government commerce, homeland security, and critical infrastructure.organizational threats. Our products, systems, and solutions also have many applications within the fire rescue, maritime, asset protection, and wildlife preservation business segments.

 

26

Genasys has developed a global market and an increased demand for LRAD AHDsLRADs and advanced outdoor mass notification speakers. We have a reputation for producing quality products that feature industry leadingindustry-leading broadcast area coverage, vocal intelligibility, and product reliability. We intend to continue building on our AHD market leadership position by offering enhanced voice broadcast systems and accessories for an expanding range of applications. In executing our strategy, we use direct sales to governments, militaries, large end-users, system integrators, and prime vendors. We have built a worldwide distribution channel consisting of partners and resellers that have significant expertise and experience selling integrated communication solutions into our various target markets. As our primary AHD sales opportunities are with domestic and international governments, military branches, and law enforcement agencies, we are subject to each customer’s unique budget cycle, which leads to long selling cycles and uneven revenue flow, complicating our product planning. 

26

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)financial planning.

 

The proliferation of natural and man-made disasters, emergency events, and civil unrest and military conflict require technologically advanced, multichannelmulti-channel solutions to deliver clear and timely critical communications to help keep people safe during crisis situations. Businesses are also incorporating critical communication and emergency management systems that locate and help safeguard employees when crises occur.

 

By providing the only SaaS platform that unifies sensors and IoT inputs with multichannel, multiagency alerting and notifications, Genasys seeks to deliver reliable, fast, and intuitive solutions for creating and disseminating geolocation-targeted warnings, information, and instructions before, during, and after public safety and business threats, critical events, and other life safety situations.enterprise threats.

 

While the software and hardware mass notification market ismarkets are more mature with many established manufacturers and suppliers, we believe that our advanced technology and unified platform provides opportunities to succeed in the large and growing public safety, emergency warning, and critical communications markets.

 

In the second half of fiscal 2022,2023, we intend to continue to pursuepursuing domestic and international business opportunities with the support of business development consultants, key representatives, and resellers. We plan to grow our revenuerevenues through increased direct sales to governments and agencies that desire to integrate our communication technologies into their defense, homeland security and public safety systems. This includes building on fiscal 20212022 domestic defense sales by pursuing further U.S. military opportunities. We also plan to pursue emergency warning, public safety and enterprise critical communications,event management, government, law enforcement, fire rescue, homeland and international security, private and commercial security, border security, maritime security, and wildlife dispersion and preservation business opportunities. In addition to the matters above, we are authorized for the performance of services and provision of goods pursuant to Delaware General Corporation Law.

 

Our research and development strategy involves incorporating further innovations and capabilities into our GEM, IMNS, Zonehaven, NEWS and LRAD products,Genasys Protect platform, systems, and solutions to meet the needs of our target markets.

 

Our GEM, IMNS, Zonehaven, and NEWS software solutions representare complex offerings that we intend to message more complex, integrated offerings.succinctly with improved and expanded marketing. We are pursuing certain certifications, which are often required when bidding on government and mass notification opportunities. We intendcontinue to invest engineering resources to enhance our GEM, IMNS, Zonehaven and NEWSGenasys Protect software solutions to compete for larger emergency warning and critical communications business opportunities. We are also configuring alternative solutions to achieve lower price points to meet the needs of certain customers or applications. We also engage in ongoing value engineering to reduce the cost and simplify the manufacturing of our products.

 

In March 2020, the World Health Organization ("WHO") classified the COVID-19 outbreak as a pandemic. While the impact of the COVID-19 pandemic did not have a material adverse effect on our financial position or results of operations for the six months ended March 31, 2022, we monitor the developments and assess areas where there is potential for our business to be impacted. A significant portion of our sales force is working remotely, which could, among other things, negatively impact our ability to engage in sales-related initiatives, or efficiently conduct day-to-day operations. Businesses and governments with which we engage may be operating under restrictions and experiencing disruptions, which may create obstacles in the coordination of business activities, including the negotiation and fulfillment of orders. Disruptions in the supply chain could negatively impact our ability to source materials or manufacture and distribute products. While we do not currently anticipate a material reduction in demand for our commercialized products, we could experience a decrease in new orders, which could negatively impact our revenues and reduce our liquidity and cash flows. Growth in revenue could also be impeded by these factors. The financial markets have been subject to significant volatility that could impact our ability to enter into, modify, and negotiate favorable terms and conditions relative to equity and debt financing activities. We have $10.3 million in cash and cash equivalents as of March 31, 2022, which we believe provides sufficient capital to fund our operations for at least the next twelve months and withstand the potential near-term consequences of the pandemic, although liquidity constraints and access to capital markets could adversely impact our liquidity and warrant changes to our investment strategy. While we have not yet experienced a material impact, the full magnitude of the pandemic cannot be measured at this time, and therefore, any of the aforementioned circumstances, as well as other factors, may cause our results of operations to vary substantially from year to year and quarter to quarter.

Based on various standards published to date, we believe the work our associates perform is critical, essential and life sustaining. We are taking a variety of measures to promote the safety and security of our employees while ensuring the availability and functionality of our critical infrastructure. We are following Center for Disease Control and local guidelines regarding COVID-19 safety in the workplace. In addition, the following events related to the COVID-19 pandemic could result in lost or delayed revenue to the Company: limitations on the ability of our suppliers to meet delivery requirements and commitments; limitations on the ability of our employees to perform their work due to illness caused by the pandemic, or local, state or federal orders requiring employees to remain at home; limitations on the ability of carriers to deliver our products to customers; unforeseen deviations from customers or foreign governments restricting the ability to do business; and, limitations on the ability of our customers to pay us on a timely basis, if at all.

27

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

A large number of components and sub-assemblies manufactured by outside suppliers within our supply chain are produced within 50 miles of our facility. We do not source component parts directly from suppliers in China, however, itChina. It is likely that some of our suppliers source parts or raw materials in China. The aftermath of the COVID-19 pandemic has adversely impactedcontinues to impact worldwide supply chains and the ability to obtain sufficient amounts of component parts, including semiconductor chips and integrated circuits, resins, coating and other equipment and components. Negative impacts on our supply chain could have a material adverse effecteffects on our business. We are in contactcommunicate with our suppliers regarding measures to mitigate ongoing worldwide supply chain issues.

We have been affected by price increases from our suppliers and evaluating what impactlogistics as well as other inflationary factors such as increased salary, labor, and overhead costs. We regularly review and adjust the sales price of our finished goods to offset these inflationary factors. Sustained or increased inflation in the future may result from COVID-19.affect our ability to achieve certain expectations in gross margin and operating expenses. If we are unable to offset the negative impacts of inflation with increased prices, our future results could be materially affected.

 

Critical Accounting Policies

 

We have identified a number of accounting policies as critical to our business operations and the understanding of our results of operations. These are described in our consolidated financial statements located in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended September 30, 2021.2022. The impact and any associated risks related to these policies on our business operations is discussed below and throughout Management’s Discussion and Analysis of Financial Condition and Results of Operations when such policies affect our reported and expected financial results.

27

 

The methods, estimates and judgments we use in applying our accounting policies, in conformity with U.S. generally accepted accounting principles, have a significant impact on the results we report in our financial statements. We base our estimates on historical experience and on various other assumptions that we believe to be reasonable under the circumstances. The estimates affect the carrying values of assets and liabilities. Actual results may differ from these estimates under different assumptions or conditions.

 

Comparison of Results of Operations for the Three Months Ended March 31, 20222023 and 20212022 (in thousands)

 

 

Three Months Ended

          

Three Months Ended

         
 

March 31, 2022

  

March 31, 2021

          

March 31, 2023

  

March 31, 2022

         
     

% of

     

% of

             

% of

     

% of

        
     

Total

     

Total

 

Fav(Unfav)

      

Total

      

Total

  

Fav(Unfav)

 
 

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues:

              

Product sales

 $11,854  90.0% $10,131  89.6% $1,723  17.0%

Product revenue

 $9,940  88.6% $11,854  90.0% $(1,914) (16.1%)

Contract and other

  1,314  10.0%  1,170  10.4%  144  12.3%  1,273  11.4%  1,314  10.0%  (41) (3.1%)

Total revenues

 13,168  100.0% 11,301  100.0% 1,867  16.5% 11,213  100.0% 13,168  100.0% (1,955) (14.8%)
              

Cost of revenues

  6,208  47.1%  6,047  53.5%  (161) (2.7%)  6,288  56.1%  5,991  45.5%  (297) (5.0%)

Gross profit

 6,960  52.9% 5,254  46.5% 1,706  32.5%

Gross Profit

 4,925  43.9% 7,177  54.5% (2,252) (31.4%)
              

Operating expenses

              

Selling, general and administrative

 5,594  42.5% 3,824  33.8% (1,770) (46.3%) 6,054  54.0% 5,811  44.1% (243) (4.2%)

Research and development

  1,893  14.4%  877  7.8%  (1,016) (115.8%)  2,281  20.3%  1,893  14.4%  (388) (20.5%)

Total operating expenses

  7,487  56.9%  4,701  41.6%  (2,786) (59.3%)  8,335  74.3%  7,704  58.5%  (631) (8.2%)
              

(Loss) income from operations

 (527) (4.0%) 553  4.9% (1,080) (195.3%)

Loss from operations

 (3,410) (30.4%) (527) (4.0%) (2,883) 547.1%
              

Other income (expense), net

  (10) (0.1%)  (8) (0.1%)  (2) 25.0%  15  0.1%  (10) (0.1%)  25  (250.0%)
              

(Loss) income before income taxes

 (537) (4.1%) 545  4.8% (1,082) (198.5%)

Income tax (benefit) expense

  (45) (0.3%)  283  2.5%  328  115.9%

Net (loss) income

 $(492) (3.7%) $262  2.3% $(754) (287.8%)

Loss before income taxes

 (3,395) (30.3%) (537) (4.1%) (2,858) 532.2%

Income tax expense (benefit)

  8  0.1%  (45) (0.3%)  (53) 117.8%

Net loss

 $(3,403) (30.3%) $(492) (3.7%) $(2,911) 591.7%
              

Net revenue

              

Hardware

 $12,495  94.9% $10,625  94.0% 1,870  17.6% $10,360  92.4% $12,495  94.9% (2,135) (17.1%)

Software

  673  5.1%  676  6.0%  (3) (0.4%)  853  7.6%  673  5.1%  180  26.7%

Total net revenue

 $13,168  100.0% $11,301  100.0% $1,867  16.5% $11,213  100.0% $13,168  100.0% $(1,955)  (14.8%)

 

The tablestable above setsets forth for the periods indicated, certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

 

28

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Revenues

 

Revenues increased $1,867, or 16.5%,were $1,955 lower compared with the same quarter in the prior year. LRAD revenues ($10,615) increased $818 and IMNS ($1,880) increased $1,054, whileHardware revenue decreased $2,135, partially offset by a $180 increase in software revenue, ($673) decreased $6, compared with the prior fiscal year quarter. HigherLower revenue in the second quarter of fiscal 20222023 was largely due to the largerlower backlog at the start of thethis fiscal year compared with the prior fiscal year amount. Softwarebacklog. The higher software revenue was essentially unchanged, reflecting lower professional services performedprimarily due to 34% increase in the current quarter, offset by higher recurring software revenue. The receipt of orders is often uneven due to the timing of budget cycles, government financial issues and military conflict. As of March 31, 2022,2023, we had aggregate deferred revenue of $982$1,811 for extended warranty obligations and software support agreementsagreements.

 

Gross Profit

The increasedecrease in gross profit compared with the same period in the prior year was due to higher hardwarecomponent costs and lower revenue in this year’s quarter. Gross profit as a percentage of sales was essentially unchangedlower compared with the prior year period (which included a favorable product mix) primarily due to greater gross profit recognized on increased hardware revenue and a more profitable revenue mixhigher costs of components, in line with inflation, in this year’s quarter.

 

As our products have varying gross margins, product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes, that may impact product costs. We have limited warranty cost experience with product updates and changes and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

 

28

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses increased $1,770, or 46.3%,$243 over the prior year quarter. The increase was largely due to $701$407 of higherincreased compensation expense and $218 from a 20% increase in sales and marketing personnel over the prior year, $443 increase in commission expense, $373 increased amortization expense, and $263 of higher travel, sales and marketing activitiesprofessional services in the current year period.period, partially offset by a $419 decrease in commission expense.

 

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the three-monthsthree months ended March 31, 2023 and 2022 of $447 and 2021 of $686, and $309, respectively.

 

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities. Commission expenses will fluctuate based on the nature of our sales.

 

Research and Development Expenses

 

Research and development expenses increased $1,016$388 in this fiscal quarter as the number of engineers increased 5% over the same quarter of last fiscal year as more engineering time was incurredwe continue to expandincrease the basefeatures and functionality of our software offering, including expansion and integration of Zonehaven into the GEM software platform, as compared with the prior year when more time was devoted to professional service contracts.offerings.

 

Included in research and development expenses for the three months ended March 31, 2023 and 2022, was $33 and 2021, was $23, and $10, respectively, of non-cash share-based compensation costs.

 

Research and development costs vary period to period due to the timing of projects, and the timing and extent of using outside consulting, design, and development firms. We seek to continually improve our product offerings, and we expect to continue to expand our product line with new products, customizations, and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

 

Net Loss

 

Net loss in the second quarter of fiscal year 20222023 was $492, a decrease of $754,$3,403, compared with thea net incomeloss of $262$492 in the second quarter of fiscal year 2021.2022. The decreaseincrease in net loss was primarily dueattributable to the increased cost of sales due to higher component costs, plus higher operating expenses, resultingwhich resulted from hiring additional engineering, sales, and marketing employees.

29

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Comparison of Results of Operations for the Six Months Ended March 31, 20222023 and 20212022 (in thousands)

 

 

Six Months Ended

         
 

March 31, 2022

  

March 31, 2021

          

March 31, 2023

  

March 31, 2022

         
     

% of

     

% of

             

% of

     

% of

        
     

Total

     

Total

 

Fav(Unfav)

      

Total

      

Total

  

Fav(Unfav)

 
 

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

  

Amount

  

Revenue

  

Amount

  

Revenue

  

Amount

  

%

 

Revenues:

  

Product sales

 $21,424  89.8% $17,081  88.4% $4,343  25.4%

Product revenue

 $19,058  87.8% $21,424  89.8% $(2,366) (11.0%)

Contract and other

  2,421  10.2%  2,248  11.6%  173  7.7%  2,642  12.2%  2,421  10.2%  221  9.1%

Total revenues

 23,845  100.0% 19,329  100.0% 4,516  23.4% 21,700  100.0% 23,845  100.0% (2,145) (9.0%)
  

Cost of revenues

  11,743  49.2%  10,350  53.5%  (1,393) (13.5%)  11,943  55.0%  11,365  47.7%  (578) (5.1%)

Gross profit

 12,102  50.8% 8,979  46.5% 3,123  34.8%

Gross Profit

 9,757  45.0% 12,480  52.3% (2,723) (21.8%)
  

Operating expenses

  

Selling, general and administrative

 10,631  44.6% 7,155  37.0% (3,476) (48.6%) 12,439  57.3% 11,009  46.2% (1,430) (13.0%)

Research and development

  3,607  15.1%  1,964  10.2%  (1,643) (83.7%)  4,216  19.4%  3,607  15.1%  (609) (16.9%)

Total operating expenses

  14,238  59.7%  9,119  47.2%  (5,119) (56.1%)  16,655  76.8%  14,616  61.3%  (2,039) (14.0%)
  

Loss from operations

 (2,136) (9.0%) (140) (0.7%) (1,996) 1425.7% (6,898) (31.8%) (2,136) (9.0%) (4,762) 222.9%
  

Other income, net

  3  0.0%  61  0.3%  (58) (95.1%)

Other income (expense), net

  (4) (0.0%)  3  0.0%  (7) (233.3%)
  

Loss before income taxes

 (2,133) (8.9%) (79) (0.4%) (2,054) 2600.0% (6,902) (31.8%) (2,133) (8.9%) (4,769) 223.6%

Income tax (benefit) expense

  (336) (1.4%)  278  1.4%  614  220.9%

Income tax expense (benefit)

  8  0.0%  (336) (1.4%)  (344) 102.4%

Net loss

 $(1,797) (7.5%) $(357) (1.8%) $(1,440) 403.4% $(6,910) (31.8%) $(1,797) (7.5%) $(5,113) 284.5%
  

Net revenue

  

Hardware

 $22,622  94.9% $18,012  93.2% 4,610  25.6% $19,945  91.9% $22,622  94.9% (2,677) (11.8%)

Software

  1,223  5.1%  1,317  6.8%  (94) (7.1%)  1,755  8.1%  1,223  5.1%  532  43.5%

Total net revenue

 $23,845  100.0% $19,329  100.0% $4,516  23.4% $21,700  100.0% $23,845  100.0% $(2,145) (9.0%)

The table above sets forth for the periods indicated, certain items of our condensed consolidated statements of operations expressed in dollars and as a percentage of net revenues. The financial information and the discussion below should be read in conjunction with the condensed consolidated financial statements and notes contained in this report.

29

 

Revenues

Revenues increased 23.4%decreased $2,145 for the six months ended March 31, 2022,2023, compared with the same prior year period, primarily due to the largerlower backlog as of September 30, 20212022, compared with September 30, 2020. LRAD2021. Hardware revenue was $18,127 fordecreased $2,677, partially offset by the current year six-month period, up $1,262, or 7.5%, IMNS revenue was $4,494, up $3,350, or 292.8%, and$532 increase in software revenue was $1,223, down $96 or 7.3% compared with the same prior year period.revenue. The receipt of orders will often be uneven due to the timing of approvals or budgets. As of March 31, 2022,2023, we had aggregate deferred revenue of $982$1,811 for extended warranty obligations and software support agreements.

 

Gross Profit

The increasedecrease in gross profit in the six months ended March 31, 20222023, was primarily due to the higher cost of components and lower sales volume. Gross profit as a percentage of revenue was highervolume this year compared to the prior year period primarily due to higher revenue and a better product mix of revenue in the currentprior year.

 

Our products have varying gross margins, so product mix may affect gross profits. In addition, our margins vary based on the sales channels through which our products are sold in a given period. We continue to implement product updates and changes, including raw material and component changes that may impact product costs. With such product updates and changes we have limited warranty cost experience and estimated future warranty costs can impact our gross margins. We do not believe that historical gross profit margins should be relied upon as an indicator of future gross profit margins.

 

30

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Selling, General and Administrative Expenses

 

Selling, general and administrative expenses increased $3,476, or 48.6%,$1,430 in the six months ended March 31, 20222023, compared with the prior year period. The increase in selling, general and administrative expenses was largely due to a $1,727an $852 increase in compensation related costs, due$579 increase in professional services expenses, and a $309 increase in sales, marketing, and travel expenses, partially offset by a $303 decrease in commission expense compared to a 30% increase of sales and marketing personnel over the prior year $374 increase in commission expense, $749 increase in amortization expense, and $586 in higher sales and marketing activities and travel.to date period.

 

We incurred non-cash share-based compensation expenses allocated to selling, general and administrative expenses in the six months ended March 31, 2023 and 2022 of $820 and 2021 of $1,217, and $479, respectively.

 

We may expend additional resources on the marketing and selling of our products in future periods as we identify ways to optimize potential opportunities. Commission expenses will fluctuate based on the nature of our sales.

 

Research and Development Expenses

 

Research and development expenses increased $1,643, as more engineering time was incurred$609, primarily due to expandincreased compensation-related costs associated with a 5% increase in headcount compared with the base software offering, including expansion and integration of Zonehaven into the GEM software platform.prior year period.

 

We incurred non-cash share-based compensation expenses allocated to research and development in the six months ended March 31, 2023 and 2022 of $52 and 2021 of $35, and $16, respectively.

 

Research and development costs vary period to period due to the timing of projects, amount of support provided on customer projects, and the timing and use of outside consulting, design, and development firms. We continually improve our product offerings, and we expect to continue to expand our product line with new products, customizations, and enhancements. Based on current plans, we may expend additional resources on research and development in the current year compared to the prior year.

 

Net Loss

 

Net loss of $1,797 for the first six months of fiscal 2022 increased $1,4402023 was $6,910, compared with a $357 net loss in the prior year period. This decreaseperiod net loss of $1,797. The increase in net loss was primarily attributable to the increased cost of sales due to thehigher component costs and higher operating expenses, partially offset by the higher revenuewhich resulted from hiring additional software engineering, sales, and gross profit, in the current year period.marketing employees.

 

Other Metrics

 

We monitor a number of financial and operating metrics, including the following key metrics,adjusted EBITDA, to evaluate our business, measure our performance, identify trends affecting our business, formulate business plans, and make strategic decisions. Our other business metrics may be calculated in a manner different than similar other business metrics used by other companies (in thousands):companies.

30

 

Adjusted EBITDA

 

Adjusted EBITDA represents our net income before other income, net income tax expense (benefit), depreciation and amortization expense, and stock-based compensation. We do not consider these items to be indicative of our core operating performance. The items that are non-cash include depreciation and amortization expense and stock-based compensation. Adjusted EBITDA is a measure used by management to understand and evaluate our core operating performance and trends, and to generate future operating plans, make strategic decisions regarding allocation of capital, and invest in initiatives focused on cultivating new markets for our solutions. In particular, the exclusion of certain expenses in calculating adjusted EBITDA facilitates comparisons of our operating performance on a period-to-period basis. Adjusted EBITDA is not a measure calculated in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”). We believe that adjusted EBITDA provides useful information to investors and others in understanding and evaluating our operating results in the same manner as our management and board of directors. Nevertheless, use of adjusted EBITDA has limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our financial results as reported under U.S. GAAP. Some of these limitations are: (1) although depreciation and amortization are non-cash charges, the intangible assets that are amortized and property and equipment that is depreciated, will need to be replaced in the future, and adjusted EBITDA does not reflect cash capital expenditure requirements for such replacement or for new capital expenditure requirements; (2) adjusted EBITDA does not reflect changes in, or cash requirements for, our working capital needs; (3) adjusted EBITDA does not reflect the potentially dilutive impact of equity-based compensation; (4) adjusted EBITDA does not reflect tax payments or receipts that may represent a reduction or increase in cash available to us; and (5) other companies, including companies in our industry, may calculate adjusted EBITDA or similarly titled measures differently, which reduces the usefulness of the metric as a comparative measure. Because of these and other limitations, you should consider adjusted EBITDA alongside our other U.S. GAAP-based financial performance measures, net income and our other U.S. GAAP financial results.

 

31

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

The following table presents a reconciliation of adjusted EBITDA to net income, the most directly comparable U.S. GAAP measure, for each of the periods indicated (in thousands):

 

 

Three months ended

 

Six months ended

  

Three months ended

 

Six months ended

 
 

March 31,

 

March 31,

  

March 31,

 

March 31,

 
 

2022

  

2021

  

2022

  

2021

  

2023

  

2022

  

2023

  

2022

 

Net loss

 $(492) $262  (1,797) (357) $(3,403) $(492) (6,910) (1,797)

Other (income) expense, net

 10  8  (3) (61)

Income tax (benefit) expense

 (45) 283  (336) 278 

Other income (expense), net

 (15) 10  4  (3)

Income tax expense (benefit)

 8  (45) 8  (336)

Depreciation and amortization

 643  270  1,282  552  639  643  1,282  1,282 

Stock-based compensation

  737   328   1,295   510   513   737   933   1,295 

Adjusted EBITDA

 $853  $1,151  $441  $922  $(2,258) $853  $(4,683) $441 

Segment Results

Segment results include net sales and operating income by segment. Corporate expense including various administrative expenses and costs of a publicly traded company are included in the Hardware segment as per historical financial reporting.

Comparison of Segment Adjusted EBITDA for the Three Months Ended March 31, 2023 and 2022 (in thousands)

  

Software

  

Hardware

 
  

Three months ended

March 31,

          

Three months ended

March 31,

         
          

Fav (Unfav)

          

Fav (Unfav)

 
  

2023

  

2022

    $    %  

2023

  

2022

    $    % 

Revenue

 $853  $673  $180   26.7% $10,360  $12,495  $(2,135)  (17.1%)

Operating (loss) Income

  (3,797)  (3,064)  (733)  23.9%  387   2,537   (2,150)  (84.7%)
                                 

Reconciliation of GAAP to Non-GAAP

                                

Depreciation and amortization

  539   547   (8)  (1.5%)  100   96   4   4.2%

Stock-based compensation

  122   67   55   82.1%  391   670   (279)  (41.6%)

Adjusted EBITDA

 $(3,136) $(2,450) $(686)  28.0% $878  $3,303  $(2,425)  (73.4%)

Software Segment

Software segment revenue increased 27% over the prior fiscal year quarter. This primarily reflects a 34% increase in recurring revenue, partially offset by a 12% decrease in professional services, compared with the prior fiscal year period.

Operating loss increased $733 in the second fiscal quarter due to increases in payroll and related costs from increased hiring to support software development and sales and higher commission expense from the increased revenues.

Hardware Segment

Hardware segment revenue decreased $2,135 compared with the prior fiscal year period. The decrease was largely due to the lower backlog at the start of this fiscal year compared with the prior fiscal year beginning backlog.

31

Operating income decreased $2,150 in the fiscal 2023 second quarter compared with the same quarter in the prior year due to lower revenue and gross profit resulting from higher cost of components, and higher professional services expense, compensation expense, and sales and marketing expenses, partially offset by lower commission expense.

Comparison of Segment Adjusted EBITDA for the Six Months Ended March 31, 2023 and 2022 (in thousands)

  

Software

  

Hardware

 
  

Six months ended

          

Six months ended

         
  

March 31,

  

Fav (Unfav)

  

March 31,

  

Fav (Unfav)

 
  

2023

  

2022

        

2023

  

2022

       

Revenue

 $1,755  $1,223  $532   43.5% $19,945  $22,622  $(2,677)  (11.8%)

Operating (loss) Income

  (7,257)  (5,845)  (1,412)  24.2%  359   3,709   (3,350)  (90.3%)
                                 

Reconciliation of GAAP to Non-GAAP

                                

Depreciation and amortization

  1,083   1,092   (9)  (0.8%)  199   190   9   4.7%

Stock-based compensation

  222   125   97   77.6%  711   1,170   (459)  (39.2%)

Adjusted EBITDA

 $(5,952) $(4,628) $(1,324)  28.6% $1,269  $5,069  $(3,800)  (75.0%)

Software Segment

Software segment revenue increased 44% over the prior fiscal year. This primarily reflects a 43% increase in recurring revenue compared with the first six months of fiscal 2022.

Operating loss increased $1,412 compared to the prior fiscal year period due to increases in payroll and related costs from increased hiring to support software development and sales, higher professional services expense, and higher commission expense from the increased revenues.

32

Hardware Segment

Hardware segment revenue decreased $2,677 compared with the prior year period. The decrease was largely due to the lower backlog at the start of this fiscal year compared with the prior fiscal year beginning backlog.

Operating income decreased $3,350 compared with the prior fiscal year due to lower revenue and lower gross profit from higher cost of components, higher sales and marketing expenses, and professional services expense, partially offset by lower commission expense.

 

Liquidity and Capital Resources

 

Cash and cash equivalents as of March 31, 20222023, was $8,977, down $4,190$6,371, compared with $13,167$12,736 as of September 30, 2021.2022. We had short-term marketable securities of $5,204$5,552 as of March 31, 2022,2023, compared with $5,686$6,397 as of September 30, 2021.2022. We had long-term marketable securities of $2,264$601 as of March 31, 2022,2023, compared with $1,875$781 as of September 30, 2021. In addition to2022. Other than cash and cash equivalents, short and long-term marketable securities, other working capital, and expected future cash flows from operating activities in subsequent periods, we have a $10 million revolving lineno unused sources of credit available as a source of liquidity.liquidity at this time.

 

Although there is uncertainty related to the impact of COVID-19 on the Company’s future results, we believe our efficient business model and strong balance sheet keep us positioned to manage our business through this crisis as it continues to unfold. We continue to manage all aspects of our business including, but not limited to, monitoring the financial health of our customers, suppliers and other third-party relationships, and developing new opportunities for growth.

 

Principal factors that could affect our liquidity include:

 

 

ability to meet sales projections;

 

government spending levels;

 

introduction of competing technologies;

 

product mix and effect on margins;

 

ability to reduce current inventory levels;

 

product acceptance in new markets;

 

value of shares repurchased;

 

value of dividends declared;

 

supply chain disruption;disruptions;

 

inflation;

 

conflict between Russia and Ukraine;

 

impact of COVID-19 on global market conditions; and

 

impact of COVID-19 on customers’ ability to pay.

33

 

Principal factors that could affect our ability to obtain cash from external sources include:

 

 

volatility in the capital markets; and

 

market price and trading volume of our common stock.

 

Based on our current cash position, and assuming currently planned expenditures and level of operations, we believe we have sufficient capital to fund operations for the twelve-month period subsequent to the issuance of the interim financial information. However, we operate in a rapidly evolving and unpredictable business environment that may change the timing or amount of expected future cash receipts and expenditures. Accordingly, there can be no assurance that we may not be required to raise additional funds through the sale of equity or debt securities or from credit facilities. Additional capital, if needed, may not be available on satisfactory terms, or at all.

 

32

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

Cash Flows

 

Our cash flows from operating, investing and financing activities, as reflected in the condensed consolidated statements of cash flows, are summarized in the table below:

 

 

Six months ended

  

Six months ended

 
 

March 31, 2022

  

March 31, 2021

  

March 31, 2023

  

March 31, 2022

 

Cash provided by (used in):

      

Operating activities

 $(3,107) $363  $(7,466) $(3,107)

Investing activities

 (146) (4,375) 918  (146)

Financing activities

 (915) (27) 41  (915)

 

Operating Activities

Net loss of $6,910 for the six months ended March 31, 2023 was decreased by $2,774 of non-cash items that included share-based compensation, warranty provision, depreciation and amortization, amortization of operating lease ROU assets, accretion of acquisition holdback liability, and inventory obsolescence. Cash used by operating activities in the current year reflected an increase in inventory of $3,469, and a decrease in accrued and other liabilities of $6,004, comprised of a decrease in the balances of customer deposits received, payment of the Canadian GST/HST and payment of incentive compensation earned in fiscal year 2022. This was offset by a $3,158 decrease in accounts receivable, a $1,840 decrease in prepaid expenses, and a $1,145 increase in accounts payable.

 

Net loss of $1,797 for the six months ended March 31, 2022 was decreased by $2,715 of non-cash items that included share-based compensation, depreciation and amortization, amortization of operating lease ROU assets, an increase to deferred income taxes, warranty provision, and inventory obsolescence. Cash used by operating activities in the current yearfirst six months of fiscal 2022, reflected an increase in inventory of $3,291, and a decrease in accrued and other liabilities and other of $4,412 reflecting a decrease in the balances of customer deposits received, and payment of incentive compensation earned in fiscal year 2021. This was offset by a $2,123 decrease in accounts receivable on lower revenue this quarterin the period compared towith the fourth quarter of fiscal year 2021, a $750 decrease in prepaid expenses and a $805 increase in accounts payable.

 

Net loss of $357 for the six months ended March 31, 2021 was offset by $1,864 of non-cash items that included depreciation and amortization, share-based compensation, operating lease ROU asset amortization, warranty provision, inventory obsolescence, both realized and unrealized loss on a foreign currency forward contract and a reduction to deferred income taxes. Cash used in operating activities for the current year reflected a decrease in accrued and other liabilities of $1,363, primarily for a $514 decrease in customer deposits resulting from shipments for the year to date and $491 of net lower accrued payroll and related liabilities, an increase of $698 in inventory to support the current backlog, a $253 increase in prepaid expenses and an increase in accounts receivable of $14. Cash provided by operating activities included an increase in accounts payable of $1,184, primarily for inventory related purchases.

We had accounts receivable of $5,550$3,623 as of March 31, 2022,2023, compared with $7,682$6,744 as of September 30, 2021.2022. Terms with individual customers vary greatly. We regularly provide thirty-day terms to our customers if credit is approved. Our receivables can vary dramatically due to overall sales volume, quarterly variations in sales, timing of shipments to and receipts from large customers, payment terms, and the timing of contract payments.

 

As of March 31, 20222023, and September 30, 2021,2022, our working capital was $16,839$15,347 and $18,019,$20,197, respectively. The decrease in working capital was primarily due to the net loss this year, changeperiod and decrease in the short-term/long-term mix of marketable securities,accounts receivable and the use of cash to repurchase shares of Company stock.prepaid expenses.

 

Investing Activities

 

Our net cash provided by investing activities was $918 for the six months ended March 31, 2023, compared with net cash used in investing activities wasof $146 for the six months ended March 31, 2022,2022. In the first six months of fiscal 2023, our holdings in short and long-term marketable securities decreased by $1,075, compared with $4,375a decrease of $25 for the six months ended March 31, 2021. In the first six months of fiscal 2021, $4,367 was used for the Amika Mobile asset purchase. In the first six months of fiscal 2022, we decreased our holdings of short and long-term marketable securities by $25, compared with a decrease of $140 in the six months ended March 31, 2021.2022.  Cash used in investing activities for the purchase of property and equipment was $171$157 and $148$171 for the six months ended March 31, 20222023 and 2021,2022, respectively. We anticipate some additional expenditures for tooling and equipment during the balance of fiscal year 2022.2023.

 

Financing Activities

 

In the six months ended March 31, 2022,2023, we used $915received $41 for financing activities, compared with $27 for$915 used in financing activities for the six months ended March 31, 2021.2022. In the first six months of fiscal 2023, we received $86 from the exercise of stock options and used $45 to settle statutory tax withholding requirements upon vesting of restricted stock units. In the first six months of fiscal 2022 we received $170 from the exercise of stock options and used $998 to repurchase shares of our common stock and $70 to settle statutory tax withholding requirements upon vesting of restricted stock units. In the first six months of fiscal year 2021 we received $170 from the exercise of stock options, which was offset by $141 of cash used to settle statutory tax withholding requirements upon vesting of restricted stock awards.

 

34

 

In December 2018, the Board of Directors approved a new share buyback program beginning January 1, 2019, and expiring on December 31, 2020, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the board voted to extend this program’s expiration date toBoard of Directors extended the buyback program until December 31, 2022. In December 2022, the Board of Directors extended the Company’s share buyback program through December 31, 2024.

There were no shares repurchased during the six months ended March 31, 2023. During the six months ended March 31, 2022, 259,310 shares were purchased for $998. No shares were repurchased during the six months ended March 31, 2021. All repurchased shares have been retired and as of March 31, 2022,2023, and $3.0 million was available for share repurchase under this program.

33

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

Recent Accounting Pronouncements

 

New pronouncements issued for future implementation are discussed in Note 3, Recent Accounting Pronouncements, to our condensed consolidated financial statements.

 

Item 3.

Quantitative and Qualitative Disclosures about Market Risk.

 

Foreign Currency Risk

 

We consider our direct exposure to foreign exchange rate fluctuations to be minimal. The transactions of our Spanish subsidiary are denominated primarily in Euros and the transactions of our Canadian subsidiary are denominated primarily in Canadian dollars, which is a natural hedge against foreign currency fluctuations. All other sales to customers and all arrangements with third-party manufacturers, with one exception, provide for pricing and payment in U.S. dollars, and, therefore, are not subject to exchange rate fluctuations. Increases in the value of the U.S. dollar relative to other currencies could make our products more expensive, which could negatively impact our ability to compete. Conversely, decreases in the value of the U.S. dollar relative to other currencies could result in our suppliers raising their prices to continue doing business with us. Fluctuations in currency exchange rates could affect our business in the future.

 

Item 4.

Controls and Procedures.

 

We are required to maintain disclosure controls and procedures designed to ensure that material information related to us, including our consolidated subsidiaries, is recorded, processed, summarized, and reported within the time periods specified in the SEC rules and forms.

 

Conclusion Regarding the Effectiveness of Disclosure Controls and Procedures

 

Under the supervision and with the participation of our management, including our principal executive officer and our principal financial officer, we conducted an evaluation of our disclosure controls and procedures as such term is defined under Rules 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934. Based on this evaluation, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective at the reasonable assurance level as of March 31, 2022.2023.

 

Changes in Internal Control over Financial Reporting

 

There have been no changes in our internal control over financial reporting during our fiscal quarter ended March 31, 2022,2023, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. Our process for evaluating controls and procedures is continuous and encompasses constant improvement of the design and effectiveness of established controls and procedures and the remediation of any deficiencies which may be identified during this process.

 

Because of the inherent limitations of internal control over financial reporting, including the possibility of collusion or improper management override of controls, material misstatements due to error or fraud may not be prevented or detected on a timely basis. Also, projections of any evaluation of the effectiveness of the internal control over financial reporting to future periods are subject to the risk that the controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings.

 

We may at times be involved in litigation in the ordinary course of business. We will also, from time to time, when appropriate in management’s estimation, record adequate reserves in our consolidated financial statements for pending litigation. Currently, there are no pending material legal proceedings to which the Company is a party or to which any of its property is subject.

 

Item 1A.

Risk Factors.

 

There have been no material changes to the risk factors described under Item 1A of our Annual Report on Form 10-K for the fiscal year ended September 30, 2021,2022, filed with the SEC on November 23, 2021, except for those noted below:

The conflict between Russia and Ukraine and the related implications may negatively impact our operations.


          In February 2022, Russia invaded Ukraine. As a result, the U.S. and certain other countries have imposed sanctions on Russia and could impose further sanctions, as well as potential retaliatory actions by Russia, that could damage or disrupt international commerce and the global economy. It is not possible to predict the broader or longer-term consequences of this conflict or the impact of sanctions, embargoes, regional instability, geopolitical shifts and adverse effects on macroeconomic conditions, security conditions, currency exchange rates and financial markets. Such geopolitical instability and uncertainty could have a negative impact on our ability to sell, ship products, collect payments, and support customers in certain regions based on trade restrictions, embargoes and export control law restrictions, supply disruptions, and logistics restrictions including closures of air space, and could increase the costs, risks and adverse impacts from supply chain and logistics challenges.

The potential effects of the conflict between Russia and Ukraine also could impact many of the other risk factors described in Item 1A, Risk Factors, in our Annual Report on Form 10-K for the fiscal year ended September 30, 2021. Given the evolving nature of this conflict, the related sanctions, potential governmental actions and economic impact, such potential impacts remain uncertain. While we expect the impacts of conflict between Russia and Ukraine could have an effect on our business, financial condition and results of operations, we are unable to predict the extent or nature of these impacts at this time.

34

Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)December 16, 2022.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds.

 

In December 2018, the Board of Directors approved a share buyback program beginning January 1, 2019 and expiring on December 31, 2020, under which the Company was authorized to repurchase up to $5 million of its outstanding common shares. In December 2020, the Board of Directors extended the buyback program until December 31, 2022.None.

The following table discloses the stock repurchases during the quarter ended March 31, 2022.

Period

 

Total Number of

Shares

Purchased

  

Average Price

Paid per Share

  

Maximum dollar value of

shares that may be purchased

under the program

 

January 1, 2022 - January 31, 2022

  142,442  $3.91  $3,053,761 

February 1, 2022 - February 28, 2022

  -  $-  $3,053,761 

March 1, 2022 - March 31, 2022

  -  $-  $3,053,761 
   142,442         

 

Item 3.

Defaults Upon Senior Securities.

 

None.

 

Item 4.

Mine Safety Disclosures.

 

Not Applicable.

 

Item 5.

Other Information.

 

None.

 

35

Item 6.

Exhibits.

 

31.1

Certification of Richard S. Danforth, Principal Executive Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

  

31.2

Certification of Dennis D. Klahn, Principal Financial Officer, pursuant to Rule 13a-14(a) or 15d-14(a) of the Securities and Exchange Act of 1934, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.*

  

32.1

Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, executed by Richard S. Danforth, Principal Executive Officer and Dennis D. Klahn, Principal Financial Officer.*

  

101.INS

Inline XBRL Instance Document*

  

101.SCH

Inline XBRL Taxonomy Extension Schema Document*

  

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document*

  

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document*

  

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document*

  

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document*

  
104Cover Page Interactive Data File (embedded within the Inline XBRL and contained in Exhibit 101)

 


*

*     Filed concurrently herewith.

 


Genasys Inc.

Notes to the Condensed Consolidated Financial Statements

(in thousands, except per share and share amounts)

(Unaudited)

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

GENASYS INC.

   

Date: May 9, 20228, 2023

By: 

/s/    Dennis D. Klahn

  

Dennis D. Klahn, Chief Financial Officer

  

(Principal Financial Officer)

 

3637